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Abstract	
	
The formation, maintenance and plasticity of synapses are essential for neural circuit 
development and the functionality of the central nervous system (CNS). While synaptogenesis is 
relatively well characterized at the neuromuscular junction (NMJ; Wu et al., 2010), the 
molecular determinants orchestrating synapse formation in the CNS are complex and not fully 
understood. The existence of organizational proteins common to both the NMJ and CNS 
synapses, however, suggests that the development of both synapses might share common 
pathways.  
A key regulator for synapse development at the NMJ is the low-density lipoprotein receptor-
related protein 4 (LRP4; Weatherbee et al., 2006; Yumoto et al., 2012; Wu et al., 2012). At the 
NMJ LRP4 forms a complex with the muscle-specific tyrosine kinase MuSK, which serves as the 
receptor for the extracellular matrix protein agrin (Kim et al., 2008; Zhang et al., 2008). This 
interaction leads to the formation of most if not all pre- and postsynaptic specializations and the 
establishment of synaptic connectivity. 
Recent studies suggest functions for LRP4 in the adult CNS, including hippocampal synaptic 
plasticity, fear-conditioning, associative and spatial learning, and LTP as well as maintenance of 
excitatory synaptic transmission (Gomez et al., 2014; Pohlkamp et al., 2015). Accordingly, lrp4 
mRNA is present in the neocortex, hippocampus, cerebellum and olfactory bulb (Tian et al., 
2006; Lein et al., 2007). However, the localization of LRP4 protein and the molecular 
mechanisms underlying its function in the CNS have not been investigated.  
In my thesis I analyzed the role of LRP4 in the CNS. I generated two rabbit antibodies against 
an intracellular and an extracellular epitope and determined the distribution of LRP4 in the 
CNS. I show that LRP4 is expressed in the adult CNS and is concentrated at synapses of many, 
but not all, neurons. Glial cells, as well as neurons generated during adult neurogenesis, do not 
express LRP4. Overexpression of LRP4 in embryonic cortical and hippocampal neuronal cultures 
resulted in the formation of more and shorter primary dendrites with an increased density of 
synapse-like specializations, whereas knockdown of LRP4 in these neurons resulted in reduced 
number of spine-like protrusions and in fewer presynaptic specializations but increased the 
length of the dendrites. Virus-mediated transsynaptic tracing revealed a reduced number of 
functional synaptic contacts in cortical neurons after knockdown of LRP4. These effects could be 
inhibited by soluble agrin as well as by anti-agrin antibodies. The effect on dendritogenesis was 
independent of MuSK since it also occurred in neurons from MuSK -/- mice. My results 
demonstrate an important role of LRP4 in dendritic arborization and synaptogenesis in 
developing CNS neurons and suggest different mechanisms of action of LRP4 at interneuronal 
synapses compared to the neuromuscular junction. 
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Zusammenfassung 
	
Die Bildung, Aufrechterhaltung und Plastizität von Synapsen ist essentiell für die Entwicklung 
von neuronalen Schaltkreisen und die Funktionalität des Zentralen Nervensystems (ZNS). 
Während die Bildung von Synapsen an der Neuromuskulären Endplatte (NMJ) bereits relativ 
gut charakterisiert wurde (Wu et al., 2010), ist der Kenntnisstand über die Synaptogenese im 
ZNS nur rudimentär.  Allerdings deutet die Existenz von Schlüsselorganisatoren, die bei der 
Bildung von beiden Synapsentypen eine wichtige Rolle spielen, auf gemeinsame Mechanismen 
hin. 
Ein Schlüsselregulator der Synapsenbildung an der NMJ ist LRP4 („low-density lipoprotein 
receptor-like protein-4“; Weatherbee et al., 2006; Yumoto et al., 2012; Wu et al., 2012). An der 
NMJ bildet LRP4 einen Komplex mit der Tyrosinkinase MuSK („muscle-specific kinase“), 
welcher als Rezeptor für das extrazelluläre Matrixprotein Agrin dient (Kim et al., 2008; Zhang et 
al., 2008). Diese Interaktion führt letztendlich zur Bildung von allen prä- und postsynaptischen 
Spezialisierungen und folgend zur Etablierung der synaptischen Transmission.  
Kürzlich konnte gezeigt werden, dass LRP4 zusätzlich Funktionen im adulten ZNS besitzt, zum 
Beispiel bei der Regulierung synaptischer Plastizität im Hippocampus, bei Furcht-
Konditionierung, assoziativem und räumlichem Lernen, bei LTP und bei der Etablierung der 
synaptischen Kommunikation (Gomez et al., 2014; Pohlkamp et al., 2015). Dementsprechend 
wird lrp4 mRNA im Neokortex, Hippocampus, Kleinhirn und Bulbus olfactorius exprimiert 
(Tian et al., 2006; Lein et al., 2007). Die Verteilung des LRP4 Proteins und die molekularen 
Mechanismen, die der Funktion von LRP4 im sich entwickelnden und adulten ZNS zugrunde 
liegen, wurden allerdings noch nicht analysiert.  
In meiner Arbeit habe ich die Rolle von LRP4 im sich entwickelnden ZNS untersucht. Ich habe 
zwei Antiseren aus Kaninchen gegen den intrazellulären- respektive den extrazellulären Teil von 
LRP4 hergestellt und mit ihnen die Verteilung von LRP4 im Gehirn untersucht. Ich zeige in 
meiner Arbeit, dass LRP4 im adulten Gehirn exprimiert wird und an vielen, aber nicht allen 
Synapsen konzentriert ist. Gliazellen sowie Nervenzellen, die während der adulten Neurogenese 
gebildet werden, exprimieren LRP4 nicht. Überexpression von LRP4 in Nervenzellen des 
embryonalen Hippocampus und Kortex bewirkt die Bildung von mehr, aber kürzeren primären 
Dendriten, die eine höhere Dichte von Synapsen-ähnlichen Spezialisierungen besitzen. Im 
Gegensatz dazu bewirkt eine stark reduzierte LRP4 Expression die Bildung von weniger Dornen-
ähnlichen Fortsätzen und einer geringeren Anzahl von präsynaptischen Spezialisierungen, aber 
eine größere Dendritenlänge. Virus-vermittelte transsynaptische Markierungen zeigen eine 
reduzierte Anzahl von funktionellen synaptischen Kontakten in Kulturen von kortikalen 
	 12 
Nervenzellen nach knockdown der LRP4 Expression. Dieser Effekt konnte durch Zugabe von 
löslichem Agrin oder von funktionshemmenden anti-Agrin Antiseren gehemmt werden. Der 
Effekt von LRP4 knockdown war unabhängig von MuSK, da er auch in Neuronen aus MuSK -/- 
Mäusen auftrat.  
Diese Ergebnisse zeigen eine wesentliche Funktion von LRP4 während der Bildung des 
Dendritenbaumes und der Synaptogenese im ZNS und deuten darauf hin, dass der molekulare 
Mechanismus der LRP4 Funktion während der Synaptogenese von interneuronalen Synapsen 
des ZNS anders ist, als an der NMJ. 	
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1 Introduction 
1.1  Neurons and synapses 
1.1.1 Historical perspective 
“... the nerve elements possess reciprocal relationships in contiguity but not in continuity. It 
is confirmed also that those more or less intimate contacts are always established, not between the 
nerve arborizations alone, but between these ramifications on the one hand, and the body and 
protoplasmic processes on the other. A granular cement, or special conducting substance would 
serve to keep the neuron surfaces very intimately in contact.” (Cajal, 1906).  
The discovery of how the nervous system is organized and works at the cellular level is one 
of the most fascinating in the history of science. One of the great pioneers of neuroscience was 
Santiago Ramon y Cajal, the first to demonstrate that the nervous system consists of individual 
neurons among which information flows at sites of contacts.  
Cajal’s histological findings were complemented by the electrophysiological work of Sir 
Charles S. Sherrington. In 1987, the British physiologist had shown that there is an electrical 
discontinuity in the circuitry of the nervous system, a “discrete gap” between nerve cells, and 
named this gap the ‘synapse’, from the Greek words syn, meaning ‘together’, and haptein, 
meaning ‘to clasp’.   
Three decades later, Otto Loewi published his famous experiment, which provided the first 
reliable evidence for existence of chemical transmission in a synapse. By the 1920s, the scientific 
community was convinced that nerve signals were electrical, and that nerves behaved like wires. 
Loewi used two frog hearts to demonstrate, in favor of Cajal’s theory, that the vagus nerve 
produced its effect on the heart by secreting a chemical substance. It was later found that this 
substance was acetylcholine.  
However, although most scientists accepted the neuron doctrine of Cajal, the definitive 
morphological proof for the synapse came only in the 1950s with the invention of the electron 
microscope that allowed the examination of the nervous tissue in higher magnification and 
revealed the synaptic ultrastructure.  
1.2 Neurons: the basic functional units of the brain 
The human brain is the most complex and sophisticated organ of all biological systems. It 
consists of approximately 1011 neurons associated with 5-10 times as many glial cells (Noctor et 
al., 2007). Even though glia outnumbers neurons by tenfold, neurons are the elementary units of 
the brain that perform the bulk of information processing. Despite the large number of different 
neuronal subtypes, all neurons share some common features: the cell body (soma), the dendrites, 
the axon, and the axon terminal. The cell body contains the nucleus and the cytoplasm 
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(perikaryon) and is involved in the neurons’ main metabolic functions, as it ensures the synthesis 
of macromolecules required for the morphology and function of a neuron. The dendrites are 
cellular extensions emerging from the soma that successively branch to form a dendritic tree. 
Together with the soma they constitute the main receptive area of neurons, as they receive 
numerous synaptic contacts from other neurons. Almost every neuron has only one long and 
thin axon extending from the soma that undergoes extensive branching at the distal end thus 
enabling communication with other cells. Research in the 1950s showed that action potentials in 
neurons of the CNS originate at the axon hillock, a specialized unmyelinated region of the soma, 
which forms the beginning of the axon (Stuart et al., 1997). Following initiation, action 
potentials can be either transmitted away from the neuron’s cell body to other neurons over long 
distances or backpropagate into the dendrites, thus providing a retrograde signal of neuronal 
output to the dendritic tree (Stuart et al., 1997). 
1.3  Overview of dendrite and spine development 
Neurons are highly polarized cells. Their two types of processes, axons and dendrites, exhibit 
great differences in morphology, molecular composition, microtubule polarity, and function. 
Primary cell cultures of neurons from the murine embryonic cortex and hippocampus provide a 
valuable model for studying mammalian neuronal development and polarity, as in this 
experimental system neurons adopt spatially and functionally distinct dendritic and axonal 
domains. The observation of single neurons in vitro revealed that they undergo morphological 
changes, which can be divided into five stages (Figure 1.1; Dotti et al., 1988). First, shortly after 
plating, neurons form lamellipodia in their periphery that several hours later are transformed into 
immature neurites, the so-called “minor processes” (stages 1 and 2). During stage 2 to 3, one of 
the minor processes begins to extend rapidly and differentiates into an axon, constituting the first 
evidence of neuronal polarity. Stage 4 is characterized by the elongation of the other minor 
processes, which will become dendrites, while in stage 5 the maturation of the axonal and 
dendritic arbors continues including dendritic branching, formation of dendritic spines and 
synaptogenesis. 
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Figure 1.1. Stages of neuronal polarization 
Schematic representation of neuronal polarization of neurons in vitro. Shortly after plating, the neurons 
form small protrusions called lamellipodia (stage 1), that develop into several immature neurites (stage 2). 
One neurite then breaks the initial morphological symmetry, extending at a rapid rate and establishing 
polarity (stage 3). The remaining neurites elongate and acquire the characteristics of dendrites (stage 4). 
Approximately seven days after plating, neurons form synaptic contacts through dendritic spines and axon 
terminals, and establish a neuronal network (stage 5). (Adapted from Arimura and Kaibuchi, 2007) 
 
The dendritic branching patterns are hallmarks of specific neuronal cell types and constitute the 
major site of information processing and integration of synaptic inputs. However, the cellular 
and molecular mechanisms that shape the dendritic arbors and regulate dendritic field formation 
remain largely unknown. Transcription factors play important roles in regulating dendrite arbor 
development, but little is known about specific target genes that they regulate (Parrish et al., 
2006, 2007). A variety of extracellular cues and their receptors are involved in dendritic 
outgrowth and branching. However, which intracellular signaling cascades mediate the effects of 
extrinsic signals that shape dendritic arbors remain unexplored (Parrish et al., 2007). Dendro-
dendritic self-avoidance, tiling and coexistence contribute to the organization of the dendritic 
fields, but the molecular mechanisms underlying dendritic organization remain unknown 
(Parrish et al., 2007). Therefore, it is crucial to determine the mechanisms involved in the 
establishment, maintenance and remodeling of dendritic fields and to what extent defects in all 
the aspects of dendritic development contribute to neurological diseases.     
1.3.1 Spines 
The dendrites of most projection neurons are covered with specialized structures called dendritic 
spines. Dendritic spines are tiny protrusions that emerge from the dendritic shaft and represent 
the main unitary postsynaptic compartment for excitatory synaptic input. Dendritic spines can 
be categorized in five groups according to their morphology: filopodia, thin spines, short and 
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stubby spines, mushroom-shaped spines, and cup-shaped spines (Figure 1.2; Hering and Sheng, 
2001). Filopodia are long (>2 µm), thin and immature protrusions, whereas mature spines 
typically have a round head and a narrow neck and the total spine volume ranges from less than 
0.01 µm3 to 0.8 µm3 (Harris, 1994, 1999). The shape and size of spines is not static and can alter 
during development, but also due to neuronal activity and plasticity. For example, during early 
developmental stages filopodia, which are considered to be the precursors of spines, are more 
abundant, and later on can convert into stubby and further into the even more stable mushroom-
shaped spines. According to the density of spines on dendritic processes, neurons can be classified 
as spiny, sparsely spiny, and aspinous (smooth; Kriegstein and Dichter, 1983). Spines contain the 
postsynaptic components of the synapse. These postsynaptic structures not only include AMPA- 
and NMDA-type glutamate receptors but also receptor interacting proteins, signal transduction 
molecules, and scaffolding proteins anchored in a matrix of cytoskeletal and signaling molecules. 
This protein dense specialization appears as an electron-dense thickening of the membrane at the 
synaptic junction and is therefore called postsynaptic density (PSD). Most spines contain a 
single, continuous PSD that corresponds to one synaptic contact. However, some PSDs appear 
to be intermittent or ‘segmented’, a condition that reflects a transition phase during spine 
division and the generation of two synapses from one (Hering and Sheng, 2001). This form of 
plasticity appears necessary for memory formation and learning. In a recent study, the dynamics 
of spines localized on the basal dendrites of CA1 pyramidal neurons was monitored, revealing a 
single population of dendritic spines with a mean lifetime of approximately 1-2 weeks (Attardo et 
al., 2015). This rapid turnover supports the idea that the transience of hippocampal-dependent 
memory directly reflects the turnover dynamics of hippocampal synapses (Attardo et al., 2015). 
  
	
Figure 1.2. Morphology of dendritic spines 
Different morphology of dendritic spines can be 
grouped into five categories: filopodia, thin 
spines, stubby spines, mushroom spines and 
branched spines. (Modified from Hering and 
Sheng, 2001).   
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1.4  Overview of synapse formation 
1.4.1 Synaptic specializations of dendrites/Synaptic structure and function 
Neurons are the functional units of the nervous system that interconnect into the functional 
neural networks underlying behavior. The capacity of a neuron to innervate and function within 
a network is mediated via specialized cell junctions known as synapses. There are two basic types 
of synapses, chemical and electrical, that are morphologically and functionally different. At 
chemical synapses, information flows in one direction: from one neuron via the release of 
neurotransmitters to an adjacent cell that detects the neurotransmitters (Pereda, 2014).  
Chemical synaptic transmission occurs between an axon terminal and a dendrite or soma of a cell 
that can be a neuron, muscle fiber, or gland cell (Pereda, 2014). Morphologically, all types of 
chemical synapses share some features as they basically consist of three components: the 
presynapse, the synaptic cleft and the postsynapse (Figure 1.3). Successful chemical transmission 
requires elaborate presynaptic molecular machinery (collectively named presynaptic 
specializations) and also a similarly complex postsynaptic molecular machinery (postsynaptic 
specializations). The presynaptic terminal is an area within the axon characterized by the 
presence of neurotransmitter-filled vesicles docked and primed at the active zone, as well as the 
machinery for the calcium-dependent exocytosis. Structurally, the postsynapse is characterized by 
an electron-dense zone (PSD), which corresponds to the region where neurotransmitter receptors 
and many associated proteins are concentrated and anchored to the cytoskeleton. The synaptic 
cleft is a 50 nm (neuromuscular junction) and 20 nm- wide (CNS synapses) gap between the 
pre- and the postsynaptic cell. Transmission at chemical synapses is initiated when an action 
potential invades the synaptic terminal and induces a depolarization of the presynaptic 
membrane. This results in a rapid and local increase of the intracellular Ca2+ concentration, 
which subsequently triggers exocytosis of synaptic vesicles and release of the neurotransmitter 
into the synaptic cleft. Subsequently, the neurotransmitter can bind to ionotropic (ligand-gated 
ion channels) and metabotropic (G protein-coupled) receptors located at the postsynaptic site 
(Sheng and Kim, 2011; Pereda, 2014).  
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Figure 1.3. Structure of 
the chemical synapse 
Chemical synapses consist of 
three components: the 
presynaptic terminal, the 
synaptic cleft and the 
postsynaptic terminal. The key 
feature of chemical synapses is 
the presence of synaptic 
vesicles filled with the 
neurotransmitters within the 
presynaptic terminal. It is these 
chemical agents that mediate 
the communication between neurons. (Modified from Pereda, 2014). 
	
In the CNS, two main categories of synapses are found: inhibitory (GABAergic and glycinergic) 
and excitatory (glutamatergic) synapses. Inhibitory synapses use gamma-aminobutyric acid 
(GABA) or glycine as their neurotransmitter. Binding to the corresponding neurotransmitter 
receptor leads to hyperpolarization of the postsynaptic site usually by chloride influx. They are 
often found at dendritic shafts close to the soma or directly at the cell body. In contrast, 
excitatory synapses are localized at dendritic spines. Glutamatergic synapses are the main type of 
excitatory synapses in the mammalian CNS. The depolarizing response to glutamate is mediated 
by three neurotransmitter-gated ion channels; AMPA, kainate and NMDA receptors. The 
establishment of all pre- and postsynaptic specializations during development is the hallmark of 
synaptogenesis and is required for successful synaptic transmission. 
1.5  The neuromuscular junction 
The neuromuscular junction (NMJ) is a specialized cholinergic synapse formed between 
presynaptic motoneurons and skeletal muscle fibers. Due to its large size and accessibility, this 
peripheral synapse has provided essential insight into synaptic transmission as well as the 
molecular mechanisms of synapse formation and maintenance (Wu et al., 2010). Defects in the 
signaling pathways associated with the development and function of the NMJ lead to a variety of 
neuromuscular disorders all characterized by use-dependent muscle weakness and fatigue, 
including congenital myasthenic syndromes (CMS) or myasthenia gravis (McConville and 
Vincent, 2002; Ferraro et al., 2012; Punga and Ruegg, 2012). 
1.5.1 Development of the neuromuscular junction 
The neuromuscular junction is by far the best-characterized synapse in the entire nervous system 
(Tintignac et al., 2015). During embryonic development motoneuron axons grow long distances 
to reach and innervate the striated muscle fibers, which constitute their distal targets. Prior to 
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motor innervation, muscle fibers already show a certain level of maturation as indicated by the 
presence of acetylcholine receptors (aneural AChRs) in the central region of the muscle. This 
phenomenon, called muscle prepatterning, appears to be nerve independent as it also occurs in 
mutant mice that lack phrenic or motor nerves (Yang et al., 2001). The muscle prepatterning is a 
transient process and is not involved in synapse formation, since it is not sufficient to establish 
neuromuscular transmission. Once the motoneuron interacts with the muscle fiber, mature 
AChR clusters (neural AChRs), form at the postsynaptic areas exactly apposed to the nerve 
terminals. 
The agrin/LRP4/MuSK pathway is the only pathway that regulates AChR aggregation and 
synapse formation in vivo. The master organizer of synaptogenesis at the NMJ is the extracellular 
matrix protein agrin. Agrin is a heparan sulfate proteoglycan (HSPG) with a molecular mass of 
>500 kD that has been originally isolated from the electric organ of Torpedo californica, where it 
is enriched in the basal lamina (Nitkin et al., 1987). Agrin was originally identified from its 
AChR clustering activity in cultured myotubes (Nitkin et al., 1987). According to the ‘agrin 
hypothesis’ (McMahan, 1990) agrin is synthesized by motoneurons, transported along the axons 
to the terminal where it is released into the synaptic cleft. In the cleft agrin becomes stably 
associated with the basal lamina by binding to laminin alpha chain and to alpha-dystroglycan. 
Basement membrane-associated agrin binds to its receptor complex consisting of dimers of LRP4 
(Kim et al., 2008; Zhang et al., 2008) and MuSK (Glass et al., 1996). This interaction initiates 
an intracellular signaling cascade leading to the formation of most if not all pre- and post-
synaptic specializations (Tintignac et al., 2015). Consistent with the agrin hypothesis, mice 
which are deficient for either agrin, MuSK or LRP4 fail to form NMJs and die at birth due to 
respiratory musculature failure and complete immobility (Gautam et al., 1996; Glass et al., 1996; 
Zhang et al., 2008; Kim et al., 2008). Moreover, ectopic expression of agrin is sufficient to 
induce locally the formation of AChR clusters in adult muscles and to elicit the formation of a 
postsynaptic apparatus in denervated muscles (Jones et al., 1997; Rimer et al., 1997) indicating 
that agrin is not only required but also sufficient for postsynaptic development.	
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1.5.1.1 Agrin cDNA and isoforms 
The full-length agrin cDNA has been cloned from several species and the amino acid sequences 
show a high degree of homology. The cDNA predicts a number of structural domains, including 
a C-terminal domain with similarity to the laminin alpha chain. This part of agrin is required 
and sufficient for its synaptogenic role at the NMJ. Alternative first exon usage generates two N-
terminal isoforms of agrin: the matrix-associated agrin (NtA-agrin), which is concentrated in the 
basal lamina of the NMJ, and the transmembrane isoform (TM-agrin), which is primarily 
expressed in the CNS. These two forms of agrin can also be alternatively spliced at two 
additional positions close to the C-terminal known as A/y and B/z sites (Kröger and Schröder, 
2002), generating multiple isoforms that differ dramatically in their distribution, in their 
biological functions, in their LRP4 binding affinity and in their ability to activate MuSK (Kim et 
al., 2008; Zhang et al., 2008). Only isoforms which contain inserts of 8, 11 or 19 amino acids at 
splice site B/z are able to interact with LRP4 and have synaptogenic function (Gesemann et al., 
1996). 
The agrin receptor complex consists of two proteins: the tyrosine kinase MuSK and the agrin 
binding protein LRP4. MuSK is a member of the large receptor tyrosine kinase (RTK) family 
that was originally discovered in a screen for tyrosine kinases in the synapse-rich electric organ of 
Torpedo (Jennings et al., 1993) and co-localizes with AChRs at NMJs (DeChiara et al., 1996). 
The role of MuSK in NMJ formation is evident in MuSK deficient mice (MuSK-/-) that, similar 
to agrin-mutant mice, lack mature NMJs, AChR clusters and other muscle-derived synaptic 
proteins and die perinatally (DeChiara et al., 1996; Gautam et al., 1996).  
Like other RTKs, MuSK is a type I transmembrane protein consisting of a glycosylated 
extracellular domain, a single transmembrane helix, and a cytoplasmic region containing a 
tyrosine kinase domain. MuSK is an atypical receptor tyrosine kinase. Typically, receptor 
tyrosine kinases are activated by ligands that bind directly to the receptor ectodomain, inducing 
dimerization and trans-autophosphorylation, thereby stimulating the catalytic kinase activity of 
the receptor (Schlessinger, 2000). However, MuSK does not bind directly to neural agrin (Glass 
et al., 1996). Instead, agrin binds to LRP4 and ligand-binding is relayed to activate the kinase 
(Kim et al., 2008; Zhang et al., 2008). MuSK and LRP4 comprise a scaffold for a plethora of 
proteins that constitute downstream signaling cascades and, more specifically, are implicated in 
NMJ assembly and the regulation of synapse-specific gene expression (Figure 1.4).   
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Figure 1.4. A working model for the agrin/LRP4/MuSK signaling pathway at the NMJ  
(A) Prior to innervation, LRP4 interacts with MuSK at basal levels to activate the pathway necessary for 
forming aneural clusters and for guiding motoneuron growth cones to the middle regions of muscle fibers. 
(B) Upon innervation, neural agrin binds to LRP4 and activates MuSK. Activation of MuSK induces an 
intracellular signaling cascade that involves the phosphorylation of several molecules leading to the 
aggregation of AChR, AChE and other protein at the synapse. Activation of MuSK induces also the 
synapse-specific gene expression via a different pathway. 
1.5.2 The family of low-density lipoprotein receptors and LRP4 
The low-density-lipoprotein receptor (LDLR) family is an ancient gene family of structurally 
closely related cell-surface receptors that have been highly conserved throughout evolution. In 
mammals, the core members of the LDLR family include the low-density-lipoprotein receptor 
(LDLR), the very-low-density-lipoprotein receptor (VLDLR), the apolipoprotein E receptor 2 
(ApoER2/LRP8), the LDL-related protein (LRP1), the LDL-related protein-1B (LRP1B), 
megalin (LRP2), and the low-density lipoprotein receptor-related protein 4 (LRP4/MEGF7) 
(Lane-Donovan et al., 2014). All core members of the LDLR family share common structural 
domains that include ligand binding domains, epidermal growth factor (EGF) homology 
domains, a membrane anchoring domain, and a cytoplasmic tail containing at least one 
consensus amino acid NPxY motif that facilitates endocytotic trafficking and signal transduction 
(Figure 1.5). Besides the core members of the LDLR family, there are several more distantly 
related LRPs that share some but not all of the structural elements that characterize the core 
members. These include LR11 (SORLA), LRP5 and LRP6 (Lane-Donovan et al., 2014). 
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Figure 1.5. The LDL receptor family 
Each member of the LDL receptor family contains a ligand-binding domain, an EGF homology domain, a 
single transmembrane segment, and at least one cytoplasmic NPxY motif. This motif serves as a docking 
site for intracellular adaptor proteins that mediate the endocytosis and signal transduction of these 
receptors (adapted from Qiu et al., 2006).  
	
The core members of the family are involved in the cellular uptake of extracellular ligands and 
regulate diverse biological processes including lipid and vitamin metabolism as well as cell-surface 
protease activity (Lane-Donovan et al., 2014). Some members of the family also participate in 
cellular signaling and regulate the development and functional maintenance of the nervous 
system (Herz and Bock, 2002). Historically, most research studies have focused on the 
importance of LDLR family members in cholesterol homeostasis. However, the discoveries that 
LDL receptors are involved in modulation of hippocampal synaptic plasticity and necessary for 
normal learning and memory have forced neurobiologists to recognize the importance of LDLRs 
in CNS function (Lane-Donovan et al., 2014). 
1.5.2.1 LRP4 
The low-density lipoprotein-related receptor 4 (LRP4; also called MEGF7) is a relatively recent 
member of the LDLR family. This protein was initially identified during a motif-trap screening 
for large mRNAs that are expressed in the human brain and contain multiple EGF-like motifs 
(MEGFs; Nakayama et al., 1998; see Figure 1.5).  
		
 
Introduction 
 
  
23 
LRP4 is a type I single transmembrane protein with about 90% of the protein being extracellular 
and only 8% intracellular. The full-length cDNA sequence of LRP4 (7784 bp; GenBankTM 
accession number AB073317) contains a 5718-nucleotide (1905 amino acid residues in human 
and rodents) open reading frame and predicts a number of domains also found in other core 
members of the LDLR family, including: a) eight cysteine-rich repeats where the (lipoprotein) 
ligands bind (LDLa), b) six domains with similarity to the epidermal growth factor (EGF-like), 
c) four type “B” repeats that contain a conserved YWTD motif and are critical for ligand release 
and recycling of the receptor (LY), d) a hydrophobic transmembrane region, and e) a cytoplasmic 
tail containing an ‘NPxY’ (Asp-Pro-any amino acid-Tyr) motif that serves as an internalization 
signal (Chen et al., 1990; see Figure 1.6). LRP4 also contains a 15-amino acid signal peptide 
sequence at the N-terminal and a PDZ domain-binding consensus sequence, -ESQV, at the C-
terminal end. The LDLa domains 6-8, the first two EGF-like domains, and the first of four β-
propeller domains constitute an approximately 50-kDa fragment that is necessary and sufficient 
to bind the appropriate agrin isoform (Zhang et al., 2011; Zong et al., 2012; see Figure 1.6). 
LDLa repeats 4-8, the first three β-propeller domains, and the two intervening EGF-like domains 
of LRP4 are sufficient to bind MuSK (Zhang et al., 2011; Zong et al., 2012; see Figure 1.6). 
The LRP4 gene and its protein domain structure are conserved across species including frogs, 
birds, rodents and primates, with the exception of the Drosophila LRP4, which does not contain 
the NPxY and the PDZ binding C-terminus, and may not be a typical LRP4 (Shen et al., 2015).  
	
Figure 1.6. Domain structure of LRP4 
The different structural domains of LRP4 and their interaction partners are indicated. LRP4 contains a 
large extracellular domain at the N-terminus, a transmembrane domain and short intracellular C-terminal 
part. The domains of LRP4 where the agrin and MuSK bind to are also indicated. For more details see 
text. 
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1.5.2.1.1 Developmental functions of LRP4 
LRP4 expression was shown to have a widespread distribution during mouse organogenesis. 
More specifically, LRP4 mRNA has been shown to be widely expressed in multiple tissues and 
organs including kidney, lungs, limb and ectodermal organs (Ohazama et al., 2008; Weatherbee 
et al., 2006). Several studies have described hypomorphic and also null mutations of LRP4 
(LRP4mitt, LRP4mte, LRP4dan, LRP4mdig, LRP4ECD/ECD) that cause a common limb phenotype 
mainly characterized by polysyndactyly in both fore and hind limbs and a mild form of 
craniofacial and tooth development abnormalities in mice and mulefoot disease in cattle 
(Johnson et al., 2006; Simon-Chazottes et al., 2006; Duchesne et al., 2006; Drögemüller et al., 
2007). In human patients more than ten point mutations in LRP4 gene have been identified 
which lead to the Cenani-Lenz syndrome, an autosomal recessive disorder characterized by 
defects in limbs and kidneys (Li et al., 2010). Moreover, mutations in LRP4 have been identified 
in patients with sclerosteosis, a disease with abnormal bone mineral density (BMD; Choi et al., 
2009). All of these data show that LRP4 plays an essential role as a modulator of the signaling 
pathways that control limb development, digit formation, and bone homeostasis. 
1.5.2.1.2 The role of LRP4 during neuromuscular junction development 
LRP4 is a key regulator for synapse development at the neuromuscular junction (NMJ). A few 
years ago, in an N-ethyl-N-nitrosourea (ENU) mutagenesis screen in mice two kinds of 
mutations of LRP4 were identified, named mitt and mte (Weatherbee et al., 2006). These are 
complete loss-of-function mutations and in both homozygous LRP4mitt and LRP4mte mice, NMJs 
do not form, motor nerve terminals fail to stop in the central region of muscle fibers and instead 
arborize extensively and AChR aggregates do not form at all. These mice die at birth due to 
respiratory musculature failure (Weatherbee et al., 2006). It was subsequently discovered that 
LRP4 interacts with MuSK and forms a tetrameric complex which serves as the receptor for agrin 
(Figure 1.7; Kim et al., 2008; Zhang et al., 2008; Zong et al., 2012).   
In the absence of agrin, LRP4 self-associates and interacts with MuSK at basal levels, resulting in 
the activation of the latter and subsequently in the prepatterning of the muscle (Figure 1.7; Kim 
et al., 2008). The binding of agrin to LRP4 triggers a reorganization of the preexisting tetrameric 
complex, promoting trans-phosphorylation and kinase activation of MuSK. Activation of MuSK 
stimulates intracellular signaling pathways that results in the formation of most, if not all, 
postsynaptic specializations including (1) clustering and anchoring of AChRs and additional 
muscle proteins that are critical for synaptic transmission, and (2) elevated transcription of 
‘synapse-specific’ genes in myofibre synaptic nuclei (Figure 1.7; Tintignac et al., 2015). LRP4 is 
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required for the relay of agrin signaling to MuSK and in the absence of LRP4, agrin’s ability to 
induce MuSK phosphorylation is minimal (Kim et al., 2008; Zhang et al., 2008). 
In addition to its role in postsynaptic differentiation of the NMJ, LRP4 has also an essential and 
early role in presynaptic differentiation in vivo. Recent studies have shown that muscle-derived 
LRP4 acts as a direct retrograde stop signal for α-motoneuron growth and promotes the 
formation of presynaptic specializations (Figure 1.7; Yumoto et al., 2012; Wu et al., 2012).  
 
	
Figure 1.7. The agrin/LRP4/MuSK complex at the neuromuscular junction 
At the neuromuscular junction, LRP4 serves as a receptor for agrin and a coreceptor for the muscle-specific 
tyrosine kinase MuSK. In the absence of agrin, LRP4 interacts with MuSK at basal levels resulting in the 
prepatterning of the muscle (A). When agrin is present, it binds to LRP4 and triggers a re-organization of 
the tetrameric complex and activation of MuSK that leads to the stimulation of the intracellular signaling 
involved in the formation of all postsynaptic specializations (B). Muscle-derived LRP4 can also act as a 
retrograde stop signal for α-motoneurons and promoting the formation of presynaptic specializations (C). 
(Modified from http://first.lifesciencedb.jp/archives/5676). 
1.5.2.1.3 Role of LRP4 in the CNS 
In the CNS, lrp4 mRNA is prominently present in the neocortex, hippocampus, cerebellum, and 
olfactory bulb (Tian et al., 2006; Lein et al., 2007). Moreover, LRP4 protein has been detected 
in postsynaptic membrane fractions prepared from the adult rat forebrain where it interacts with 
the postsynaptic scaffold protein PSD95 (Tian et al., 2006; Gomez et al., 2014). Thus, in 
addition to its essential role at the NMJ, these studies suggested functions for LRP4 in the adult 
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CNS (Gomez et al., 2014; Pohlkamp et al., 2015). LRP4-/- mice rescued for LRP4 expression 
selectively in muscle but lacking LRP4 in the brain (LRP4-/-; LRP4m) exhibit impaired synaptic 
hippocampal plasticity, reduced LTP as well as excitatory synaptic transmission defects, and 
deficits in cognitive tasks that assess learning and memory, including fear-conditioning (Gomez 
et al., 2014). Similarly, mice expressing only the extracellular domain of LRP4 (LRP4ECD/ECD) 
show deficits in LTP, without exhibiting major changes in the general anatomy of the brain 
(Pohlkamp et al., 2015). The cellular and molecular basis of these deficits remains unknown. 
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Aim of the study 
While the aforementioned studies unequivocally show an essential role of LRP4 during 
formation and maintenance of the NMJ, its role during CNS development is unclear. In 
particular, the molecular basis of the altered behavior in LRP4-deficient mice is unclear. The aim 
of this thesis project therefore was: 
1. To determine the overall localization of LRP4 in embryonic and adult mouse CNS, and 
more specifically to determine whether LRP4 is present in neurons. 
2. To investigate the subcellular distribution of LRP4, in particular to determine if LRP4 is 
concentrated at CNS synapses, as it is at the NMJ and if yes, at which synapses.  
3. To investigate the effect of an overexpression and knockdown of LRP4 in CNS neurons.  
		 28 
		
 
Materials and Methods 
 
  
29 
2 Materials and Methods 
 
Use and care of animals was approved by German authorities and according to national law 
(TierSch§7). For this study, C57BL/6J wild-type mice were bred in the animal facility of the 
Institute of Physiology of LMU Munich. The day of the vaginal plug was considered embryonic 
day (E) 0. Mice with a targeted deletion of the MuSK gene have been described previously 
(DeChiara et al., 1996). Mice obtained from crosses between GLASTCreERT2 and CAG-CAT-
eGFP (GLAST::CreERT2/eGFP) have been previously characterized (Bardehle et al., 2013). All 
experimental procedures were performed in accordance with German and European Union 
guidelines. 
2.1  Materials 
2.1.1 Primary antibodies 
Table 1. Primary antibodies 
 
Antigen Host 
species 
WB ICC IHC Supplier Cell type 
labelled 
Agrin 204 rabbit - 1:1000 1:500 Prof.M. Rüegg, 
Basel, 
Switzerland 
NMJ, CNS 
synapses 
α-tubulin mouse 
IgG1 
1:3000 - - Sigma, 
Hamburg, 
Germany 
Major 
constituent of 
microtubules 
(loading 
control in 
Western 
blotting) 
Bassoon rabbit - 1:1000 - Dr. Wilko D. 
Altrock, 
Magdeburg, 
Germany 
Presynaptic 
nerve terminals 
beta-III-
tubulin (Tuj1) 
mouse 
IgG2b 
- 1:500 - Sigma, 
Hamburg, 
Germany 
Immature 
neurons 
Calbindin mouse 
IgG1 
- 1:500 1:500 Sigma, 
Hamburg, 
Germany 
Short-axon 
cells, Purkinje 
neurons, DG 
granule 
neurons 
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CamKII mouse 
IgG1 
- 1:500 - Abcam, 
Cambridge, UK 
Glutamatergic 
neurons 
Doublecortin 
(Dcx) 
guinea pig - - 1:300 Millipore, 
Schwalbach, 
Germany 
Immature DG 
granule 
neurons 
γ-Amino 
butyric acid 
(GABA) 
rabbit - 1:200 - Sigma, 
Hamburg, 
Germany 
GABAergic 
neurons 
(interneuron) 
Glial fibrillary 
acidic protein 
(GFAP) 
mouse 
IgG1 
- 1:500 1:500 Sigma, 
Hamburg, 
Germany 
aNSCs, 
astrocytes 
Green 
fluorescent 
protein (GFP) 
chicken - 1:500 1:500 Abcam, 
Cambridge, UK 
eGFP-labeled 
cells 
Lrp4 (int.) rabbit 1: 
10.000 
1:1000 1:300 Self-made  
Lrp4 (int.) rabbit 1: 
10.000 
1:1000 1:300 Sigma, 
Hamburg, 
Germany 
 
Lrp4 (ext.) rabbit 1: 
10.000 
1:1000 1:300 Self-made  
Lrp4 (ext.) rabbit 1: 
10.000 
1:1000 1:300 Sigma, 
Hamburg, 
Germany 
 
MAP-2 mouse 
IgG1 
- 1:500 - Sigma, 
Hamburg, 
Germany 
Dendritic 
processes  
Neurofilament 
heavy chain 
(NFH) 
chicken - - 1:300 Millipore, 
Schwalbach, 
Germany 
Filaments in 
axons 
Neuronal 
Nuclei 
(NeuN) 
mouse 
IgG1a 
- - 1:300 Millipore, 
Schwalbach, 
Germany 
Nuclei of 
postmitotic 
neurons 
PSD95 mouse 
IgG2a 
- 1:200 - Thermo Fischer 
Scientific, 
Nidderau, 
Germany 
Postsynaptic 
terminals 
Red 
fluorescent 
protein (RFP) 
rat IgG2a - 1:400 - Chromotek, 
Planegg-
Martinsried, 
Germany 
DsRed/RFP-
labeled cells 
S100β mouse - 1:500 - Sigma, 
Hamburg, 
Germany 
Astrocytes 
(adult brain) 
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Synaptobrevin 
2 
mouse 
IgG1 
- 1: 
1000 
- SySy, Göttingen, 
Germany 
Presynaptic 
terminals 
Tau mouse 
IgG2a 
- 1:200 - Millipore, 
Schwalbach, 
Germany 
Axonal 
processes 
Vesicular 
Glutamate 
transporter 1 
(Vglut1) 
guinea pig - 1: 
2.500 
1: 
25.000 
Millipore, 
Schwalbach, 
Germany 
Presynaptic 
terminals 
 
WB: dilution used for Western blotting, ICC: dilution used for Immunocytochemistry, IHC: 
dilution used for Immunohistochemistry. 
2.1.2 Secondary antibodies 
Table 2. Secondary Antibodies 
 
Species specificity Fluorescence tag Dilution Supplier 
Goat α-mouse IgG 
 
Goat α-mouse IgG 
Goat α-mouse IgG 
Goat α-mouse HRP 
Alexa Fluor® 488 
 
Cy3 
Alexa Fluor® 647 
 
1:1000 
 
1:500 
1:1000 
1:3000 
Molecular Probes, Nidderau, 
Germany 
Jackson, Suffolk, UK 
Invitrogen, Darmstadt, Germany 
Invitrogen, Darmstadt, Germany 
Goat α-mouse IgG1 
Goat α-mouse IgG1 
Alexa Fluor® 488 
biotin 
1:1000 
1:200 
Invitrogen, Darmstadt, Germany 
Invitrogen, Darmstadt, Germany 
Goat α-mouse IgG2a 
Goat α-mouse IgG2a 
Alexa Fluor® 488 
TRITC 
1:1000 
1:1000 
Invitrogen, Darmstadt, Germany 
Invitrogen, Darmstadt, Germany 
Goat α-rabbit IgG 
Goat α-rabbit IgG 
Alexa Fluor® 488 
Alexa Fluor® 647 
1:1000 
1:1000 
Invitrogen, Darmstadt, Germany 
Invitrogen, Darmstadt, Germany 
Biotinylated secondary Streptavidin FITC 1:200 Invitrogen, Darmstadt, Germany 
Biotinylated secondary Streptavidin Cy3 1:200 Invitrogen, Darmstadt, Germany 
α-bungarotoxin Alexa Fluor® 594 1:1000 Invitrogen, Darmstadt, Germany 
	
2.1.3 Buffers and solutions 
Table 3. Buffers and solutions 
 
Buffer/Solution Components Preparation Use 
Ampicillin stock, 100 
mg/ml 
1 g Ampicillin 
Autoclaved ddH2O 
Dissolve powder in 10 ml 
autoclaved ddH2O. Make 
aliquots and store at -20oC. 
To prepare 
agar plates for 
selecting 
bacterial 
colonies. 
4’, 6’-diamidino-2- 2 mg DAPI Dissolve powder in 1 ml 1x To visualize 
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phenylindole (DAPI) 
stock,  
2 mg/ml 
1 ml 1x PBS 
 
PBS. Store at -20oC. nuclei in IHC 
and ICC. 
Ethylene-diamine-
tetraacetic acid, 
disodium salt (EDTA), 
0.5 M pH 8.0 
18.6 g EDTA 
disodium salt powder 
1 N NaOH 
ddH2O 
Dissolve powder in 50 ml 
ddH2O and adjust the pH 
with NaOH. Top up the 
solution to ta final volume of 
100 ml. Autoclave. 
To prepare 
50x TAE 
buffer. 
Kanamycin stock,  
100 mg/ml 
1 g Kanamycin 
Autoclaved ddH2O 
Dissolve powder in 10 ml 
autoclaved ddH2O. Make 
aliquots and store at -20oC. 
To prepare 
agar plates for 
selecting 
bacterial 
colonies. 
Lysis buffer (10X) 5 ml Tris – HCl (1M) 
pH 7.5 
10 ml EDTA (0.5M) 
ddH2O 
Dissolve components in up 
to 50 ml ddH2O. Store at 
RT. 
Diluting to 
1X lysis 
buffer. 
Paraformaldehyde, 
20% (20% PFA) 
134 g 
Na2HPO4.2H2O 
100 g PFA (Sigma) 
10 ml NaOH, 32% 
7 ml HCl. 37% 
Dissolve Na2HPO4.2H2O in 
1600 ml autoclaved ddH2O 
and heat to 60oC while 
stirring. Stop heating and 
add PFA to the heated 
solution and dissolve 
completely by adding 
NaOH. Let the solution 
cool on ice and adjust pH to 
7.4 with HCl. Store at  
-20oC. 
Diluting to 
4% PFA. 
Paraformaldehyde, 4% 
(4% PFA) 
20% PFA 
Autoclaved ddH2O 
Dilute 50 ml 20% PFA in 
200 ml ddH2O. Store at 
4oC. 
Fixative. 
Phosphate buffered 
saline, 0.15 M (10x 
PBS) 
400 g NaCl 
10 g KCl 
58.7g 
Na2HPO4.2H2O 
10 g K2HPO4 
Dissolve components in up 
to 5 l ddH2O and autoclave. 
pH of the solution should be 
ca. 7.4. Store at RT. 
Diluting to 
1x PBS. 
Phosphate buffered 
saline, 1x (1x PBS) 
10x PBS 
Autoclaved ddH2O 
Dilute 100 ml 10x PBS in 
900 ml ddH2O. Store at RT. 
Washing for 
IHC and 
ICC. 
Phosphate-buffered 
saline, 0.1% Tween 20 
(PBST) 
100 ml PBS 
1 ml Tween 20 
900 ml ddH2O 
Mix all components. Store at 
RT.  
Washing 
membranes 
for Western 
blotting. 
Phosphate buffer, 0.25 6.5 g Dissolve Na2HPO4.2H2O in To prepare 
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M (10x PB) Na2HPO4.2H2O 
1.5 g NaOH 
Autoclaved ddH2O 
up to 40 ml autoclaved 
ddH2O. Adjust pH to 7.4 
using NaOH and make up 
volume to 50 ml with 
ddH2O. 
storing 
solution. 
Poly-D-Lysine (PDL; 
molecular weight > 300 
kDa) stock solution, 1 
mg/ml 
PDL powder 
ddH2O 
Concentration: 1 
mg/ml 
Dissolve 50 mg PDL powder 
in sterile ddH2O to make a 
stock solution of 1 mg/ml. 
Filter sterilize. Store 1 ml 
aliquots at -20oC. 
Stock 
solution for 
coating of 
coverslips. 
Poly-D-Lysine (PDL) 
working solution 
1 ml PDL stock 
solution 
50 ml 1x PBS 
Add 1 ml stock solution in 
49 ml sterile 1x PBS. Filter 
sterilize and use it 
immediately.  
Coating of 
coverslips for 
cell culture. 
RIPA buffer 50 mM Tris-HCl pH 
8.0 
150 mM NaCl 
1% DOC (Sodium 
Deoxycholate) 
1% NP-40 
0.1% SDS 
Protease Inhibitors 
Autoclaved ddH2O 
Dissolve DOC in autoclaved 
ddH2O. Add Tris-HCl, 
NaCl and NP-40 and 
ddH2O up to the final 
volume. Store at 4oC. Before 
use, add SDS and the 
protease inhibitors tablet (1 
tablet/20 ml RIPA). 
Lysis buffer 
for cells. 
SDS running buffer 
(10x) 
30.3 g Tris base (0.25 
M) 
144 g Glycine (1.92 
M) 
10 g SDS [1% (w/v)] 
Autoclaved ddH2O 
Dissolve the components in 
800 ml autoclaved ddH2O 
while stirring. Make up 
volume to 1 l with ddH2O. 
Store at RT. 
To prepare 
running 
buffer (1x) 
for SDS-
PAGE. 
Storing solution (cryo-
protectant) 
30 ml Glycerol 
30 ml Ethyleneglycol 
10 ml 10x PB 
Autoclaved ddH2O 
Dissolve the components in 
30 ml autoclaved ddH2O 
while stirring. Adjust pH to 
7.4. Store at 4oC. 
To store free-
floating tissue 
sections. 
Sucrose solution, 30% 15 g Sucrose 
50 ml 1x PBS 
Dissolve the sucrose in 30 
ml 1x PBS while stirring. 
Make up volume to 50 ml 
with 1x PBS. Store at 4oC. 
To cryo-
protect fixed 
tissue before 
cryo-
sectioning.  
Transfer buffer (10x) 2.42 g Tris base 
11.52 g Glycine 
ddH2O 
Dissolve the components in 
800 ml autoclaved ddH2O 
while stirring. Make up 
volume to 1 l with ddH2O. 
Store at RT. 
To prepare 
transfer 
buffer (1x) 
for Western 
blotting. 
Transfer buffer (1x) 2.42 g Tris base Dissolve the Tris base and Transfer 
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11.52 g Glycine 
160 ml Methanol 
ddH2O 
glycine in 700 ml ddH2O 
while stirring. Add 
methanol. Make up volume 
to 1 L with ddH2O. Store at 
4oC.  
buffer for 
Western 
blotting. 
Transformation buffer 
I 
1.47 g Kac (30 mM) 
6.05 g RbCl (100 
mM) 
0.74 g CaCl2 x 2H2O 
(10 mM) 
75 ml Glycerin (15%) 
4.95 g MnCl2 x 4H2O 
(50 mM) 
conc. HCl 
Autoclaved ddH2O 
Dissolve the components in 
400 ml autoclaved ddH2O 
while stirring. Adjust pH to 
5.8 using HCl and make up 
volume to 500 ml with 
ddH2O. Filter sterilize and 
store at 4oC.   
To prepare 
chemo-
competent E. 
coli. 
Transformation buffer 
II 
0.21 g MOPS (10 
mM) 
1.10 g CaCl2 x 2H2O 
(75 mM) 
0.12 g RbCl (10 mM) 
15 ml Glycerin (15%) 
conc. HCl 
Autoclaved ddH2O 
Dissolve the components in 
70 ml autoclaved ddH2O 
while stirring. Adjust pH to 
6.5 using HCl and make up 
volume to 100 ml with 
ddH2O. Filter sterilize and 
store at 4oC.   
To prepare 
chemo-
competent E. 
coli. 
Tris-Acetate-EDTA 
buffer (TAE), 50x 
242 g Tris base 
57.1 ml glacial acetic 
acid 
100 ml 0.5 M EDTA 
ddH2O 
Dissolve the Tris base in ca. 
750 ml ddH2O. Add glacial 
acetic acid and EDTA and 
make up volume to 1 l with 
ddH2O. pH should be ca. 
8.5. Autoclave. Store at RT. 
To prepare 1x 
TAE buffer 
for 
electrophoresi
s of agarose 
gels. 
Tris-Acetate-EDTA 
buffer (TAE), 1x 
20 ml 50x TAE 
ddH2O 
Dilute 20 ml 50x TAE 
buffer in up to 1 l ddH2O. 
Store at RT. 
Running 
buffer for 
agarose gels. 
Tris-buffered saline 
(TBS), 10x 
24 g Tris base 
88 g NaCl 
conc. HCl 
ddH2O 
Dissolve the components in 
900 ml ddH2O while 
stirring. Adjust the pH to 
7.6 using HCl and make up 
volume to 1 L with ddH2O. 
Diluting to 
1x TBS. 
Tris-buffered saline, 
0.1% Tween 20 
(TBST) 
100 ml TBS 10x 
1 ml Tween 20 
900 ml ddH2O 
Mix all components. Store at 
RT. 
Washing 
membranes 
for Western 
blotting. 
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2.1.4 Media 
Table 4. Media for cell and bacterial culture 
 
Medium Components Notes 
LB Agar Add 10 g Bacto-tryptone, 5 g Yeast extract, 10 
g NaCl and 15 g Agar to 800 ml ddH2O. Mix 
until the components are dissolved. Adjust pH 
to 7.5 with NaOH. Adjust volume to 1 L with 
ddH2O. Autoclave. Add antibiotic when agar 
cools to ca. 50-60oC. 
Growing bacteria for 
transformation/cloning. 
Makes ca. 20 x 10 cm plates. 
LB Broth Add 10 g Bacto-tryptone, 5 g Yeast extract and 
10 g NaCl to 800 ml ddH2O. Mix until the 
components are dissolved. Adjust pH to 7.5 
with NaOH. Adjust volume to 1 L with 
ddH2O. Autoclave. 
Growing bacteria for 
transformation/cloning. 
E14 
differentiation 
medium 
Neurobasal medium 
1x PenStrep (100x; Sigma) 
1x Glutamax (100x; Sigma) 
B27 supplement (Gibco) 
Medium for differentiation 
of E14 cortical neuronal 
culture. Add 1 ml B27 
supplement to a final volume 
of 50 ml medium. 
	
2.1.5 Cell lines 
Table 5. Prokaryotic and eukaryotic cell lines 
 
Bacterial strains: E. coli TOP10 (Invitrogen) 
 E. coli BL21 
 E. coli Dh5alpha (Invitrogen) 
 
Eukaryotic cell lines: HEK 293 cells (generous gift of Dr. Alex Lepier) 
	
2.1.6 Oligonucleotides 
	
Primer 
name 
Sequence (5’ à  3’) 
 
Description 
mir1232 
Top 
Strand 
5’-
TGCTGTTAACATTGCAGTTCTCCTCAGTTTTGGC
CACTGACTGACTGAGGAGATGCAATGTTAA -3’ 
 
 
 
 
 
 
 
mir1232 
Bottom 
Strand 
5’-
CCTGTTAACATTGCATCTCCTCAGTCAGTCAGTG
GCCAAAACTGAGGAGAACTGCAATGTTAAC -3’ 
mir1544 
Top 
5’-
TGCTGTTCAGTAGCAGCGTGTACTCGGTTTTGG
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Strand CCACTGACTGACCGAGTACACTGCTACTGAA -3’  
 
Linker 
microRNA target 
sequence 
(sense/antisense) 
Loop sequence	
mir1544 
Bottom 
Strand 
5’-
CCTGTTCAGTAGCAGTGTACTCGGTCAGTCAGTG
GCCAAAACCGAGTACACGCTGCTACTGAAC -3’ 
mir6854 
Top 
Strand 
5’-
TGCTGTGTTGAGCCAGTCTTTGAAAGGTTTTGGC
CACTGACTGACCTTTCAAACTGGCTCAACA -3’ 
mir6854 
Bottom 
Strand 
5’-
CCTGTGTTGAGCCAGTTTGAAAGGTCAGTCAGTG
GCCAAAACCTTTCAAAGACTGGCTCAACAC -3’ 
mir7072 
Top 
Strand 
5’-
TGCTGTAAAGGAGCATGAAGCTAATGGTTTTGGC
CACTGACTGACCATTAGCTATGCTCCTTTA -3’ 
mir7072 
Bottom 
Strand 
5’-
CCTGTAAAGGAGCATAGCTAATGGTCAGTCAGTG
GCCAAAACCATTAGCTTCATGCTCCTTTAC -3’ 
	
2.1.7 Plasmids 
	
Plasmid Source 
pCR-LRP4-TOPO ImaGenes 
pCDNA3.1(-) Myc-His B Invitrogen 
pCMV-LRP4 Personally cloned 
pCMV-LRP4-IRES-eGFP Personally cloned 
pCMV-LRP4ext. Cloned by Katja Peters 
pCAG-eGFP Generous gift of Dr. Alex Lepier 
pCAG-RFP Generous gift of Dr. Alex Lepier 
pSYN-GFP:actin Generous gift of Dr. Sergio Gascon 
pSYN-LRP4 Personally cloned 
pcDNATM6.2-GW Invitrogen 
pcDNATM6.2-GW/EmGFP Invitrogen 
pcDNATM6.2-GW/mir1232 Personally cloned 
pcDNATM6.2-GW/mir1544 Personally cloned 
pcDNATM6.2-GW/mir6854 Personally cloned 
pcDNATM6.2-GW/mir7072 Personally cloned 
pcDNATM6.2-GW/mir1232_1544 Personally cloned 
pENTR1A_Myc_DsRed+kozak_MCS Generous gift of Dr. Sergio Gascon 
pENTR1A_Myc_DsRed+kozak_mir1232_1544 Personally cloned 
pCAGGS-Dest Generous gift of Dr. Alex Lepier 
pCAG-miRLRP4-RFP Personally cloned 
pSYN-TMAgrin Cloned by Anna Schick 
pCAG-DsRedExpress-T2A-Glyco-IRES-TVA Cloned by Dr. Aditi Deshpande 
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2.2  Methods 
2.2.1 DNA/RNA methods 
2.2.1.1 RNA extraction from tissue and cDNA synthesis 
To extract RNA from tissue, 1 mL of Trizol was used per 50-100 mg of tissue and the tissue was 
homogenized in sterile homogenators. Samples were incubated for 5 min at room temperature 
and 200 µl of chloroform per 1 mL of Trizol was added. Samples were mixed by vortexing for 15 
sec, incubated for 10 min at room temperature and centrifuged at 11300 rpm for 15 min at 4oC. 
After centrifugation, samples have separated into two phases: the upper aqueous phase is colorless 
and contains the RNA. The organic phase is reddish, contains DNA and proteins in the 
phenol/chloroform solution. For the RNA precipitation, the aqueous phase was carefully 
removed and 500 µl of isopropanol per 1 mL of initial Trizol volume was added. Samples were 
mixed by inverting the tubes 5-6 times and centrifuged at 11300 rpm for 8 min at 20oC. The 
precipitated RNA was washed with 75% ethanol (1 mL of ethanol per 1 mL of Trizol) and 
centrifuged at 8900 rpm for 5 min at 20oC. Supernatant was removed and the pellet (that 
contains the RNA) was air-dried and re-dissolved in H2O.    
The protocol was performed under sterile conditions (all reagents were RNAse-free). The 
purified RNA was subsequently used for cDNA synthesis.   
To extract RNA from cells a similar procedure was followed as for tissue. The cells that were 
adherent and grew in a monolayer were mechanically lysed in the flask by adding Trizol, after 
removing the medium. The cells that were in solution were first centrifuged and then lysed by 
adding Trizol. The amount of Trizol added was 1 ml per 10-cm2 surface or 1 ml per 5-10 x 106 
cells. A homogenator or a 1 ml syringe was used for the homogenization of the cells.   
In order to synthesize cDNA using the total RNA as template, the iScript cDNA synthesis kit 
(Bio-Rad, California, USA) was used according to the manufacturer’s instructions. A typical 
cDNA synthesis reaction was prepared as follows: 
 
5X cDNA synthesis kit buffer 4 µl 
iScript enzyme mixture 1 µl 
RNA sample 1 µg 
Nuclease-free H2O ad 20 µl 
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2.2.2 Biochemical methods 
2.2.2.1 Cell/tissue lysis 
For preparation of HEK293 and neuronal cell lysates, cells cultured in 6-well plates were lysed 
with RIPA buffer with the addition of complete protease inhibitor cocktail (ROCHE, 
Mannheim, Germany). An adequate amount of RIPA was added to the cells (e.g. 150 µl per 35 
mm dish of cultured cells) and cells were lysed using a cell scraper. Lysates were incubated on ice 
for 30 min and cleared by centrifugation at 13000 rpm form 15 min at 4oC. Supernatant was 
collected and protein concentration was determined using the Bradford assay.  
For preparation of adult mouse brain protein, tissue was homogenized in 10 volumes w/v lysis 
buffer. After homogenization with a glass-Teflon homogenizer, lysates were centrifuged at 3500 
rpm for 30 min at 4oC to remove cellular debris. For the membrane protein fractions, 
supernatant was centrifuged at 15000 rpm for 30 min at 4oC and the pellet was re-suspended in 
10 mM Tris 7.4. Protein concentration was determined using the Bradford assay and samples 
were stored at -80oC.		
	
2.2.2.2 Sodium docecylsulfate poly-acrylamide gel electrophoresis and Western 
blotting 
Separating gel: 
Gel 
Perce-
ntage 
Acrylamide 
(ml) 
1.5 M Tris, 
pH 8.8 
(ml) 
20% 
SDS 
(µl) 
ddH2O 
(ml) 
10% 
APS 
(µl) 
TEMED 
(µl) 
Final 
volume 
(ml) 
7% 1.87 2 40 3.97 80 6 8 
10% 2.67 2 40 3.17 80 3 8 
12% 3.2 2 40 2.64 80 3 8 
15% 4 2 40 1.84 80 3 8 
 
Stacking gel: 
 
Acrylamide 
(µl) 
0.5 M Tris, 
pH 6.8 
(µl) 
20% 
SDS 
(µl) 
ddH2O 
(ml) 
10% APS 
(µl) 
TEMED 
(µl) 
Final 
volume 
(ml) 
850 625 25 3.4 50 5 5 
 
Sodium docecylsulfate poly-acrylamide gel electrophoresis (SDS-PAGE) was performed using the 
vertical Mini-PROTEAN 3 gel system (BIO-RAD). Gels were polymerized using the 
corresponding gel casting system. After pouring the separation gel, isopropanol was added on top 
to avoid dehydration of the gel and to obtain a sharp border between running and stacking gel. 
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As soon as the separating gel was polymerized, the isopropanol was removed and the stacking gel 
was poured, pushing at the same time a comb in the gel. After the stacking gel was polymerized, 
protein samples could be loaded and electrophoresis was performed in 1x running buffer first at 
80V and then at 140-160V when probes had entered the separation gel. 
Transfer buffer was stored at 4oC. Whatman sheets and a nitrocellulose membrane were cut to 
the size of the gel and soaked in transfer buffer, additionally to the sponge pads. The gel and the 
membrane were sandwiched between soaked pieces of sponge pads, Whatman paper and 
perforated plastic plates. 
The transfer was performed in a blotting tank (Biorad) overnight at 4oC 30V constant current. 
After transfer of the proteins onto the nitrocellulose membrane, the membrane was washed in 1x 
PBST in order to completely remove the methanol. To avoid nonspecific binding, the membrane 
was incubated in blocking solution [1x PBST, 5% (w/v) skimmed milk] for 2-3 hours at RT. 
Incubation of the membrane with primary antibodies for 2-4 hours at RT or overnight at 4oC 
followed. Membranes were washed thrice in 1x PBST or TBST and incubated with specific 
secondary antibodies conjugated to horseradish-peroxidase (HRP, dilution 1:10.000 in blocking 
buffer) at RT for 1-2 hours. Immunoreactive proteins were visualized with a chemiluminescent 
substrate (ECL-kit; GE Healthcare, Little Chalfont, UK) on Hyperfilm ECL (Amersham, 
Amersham, UK) films. 
2.2.3 Cell culture methods 
Before PDL coating, the glass coverslips were thoroughly washed in acetone for 1 h at 4 oC 
followed by 0.1 M HCl in 70% ethanol for 1 h at 4 oC. Finally, they were rinsed in 100% 
ethanol and dried on a paper towel under the laminar flow hood. For coating, coverslips were 
transferred to a 24-well plate and 500 µL poly-D-lysine (PDL) working solution was added in 
each well. Incubation for at least 2 h or overnight at 37 oC followed. PDL was aspirated and 
coverslips were thoroughly washed with sterile double distilled water. Plates were dried under the 
laminar flow hood and stored at 4 oC for up to one week. 
2.2.3.1 Preparation and transfection of embryonic cortical and hippocampal 
cultures 
Cultures were prepared from timed pregnant C57BL/6 female mice at E14-16. The day of 
vaginal plug detection was considered day 0. Females were sacrificed by cervical dislocation and 
the abdominal cavity was cut open to expose the uteri containing the embryos. After removal of 
the uterine tissue and placenta, embryos were transferred to a 60-cm dish containing ice-cold 
Hanks buffered salt solution with 10 mM Hepes buffer (HBSS-Hepes). Embryos were 
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decapitated and the brains were isolated in a 60-cm dish with HBSS-Hepes under a dissecting 
binocular microscope (Leica, Wetzlar, Germany). The hindbrain was removed, the hemispheres 
were separated and the meninges were stripped away. Cortices or hippocampi from both 
hemispheres were dissected out and transferred to a 15-mL tube filled with ice-cold HBSS-
Hepes. Under a tissue culture flow hood, the HBSS-Hepes was carefully aspirated with a Pasteur 
pipette and 3 mL fresh HBSS-Hepes were added to the cortices. The tissue was then 
mechanically dissociated using a 1000-µL pipette. The cell suspension was centrifuged at 1000 
rpm for 5 minutes and the supernatant was discarded. The cell pellet was resuspended in 1 mL 
culturing medium and the total cell number was determined using an improved Neubauer 
chamber. Cells were seeded onto glass coverslips coated with PDL at a density of 200,000 
cells/well (of a 24-well plate). The culturing medium used was Neurobasal medium with 
Glutamax, B27 supplements (Invitrogen, Darmstadt, Germany) and penicillin/streptomycin (1x; 
Invitrogen, Darmstadt, Germany). Transfections with Lipofectamine 2000 (Invitrogen, 
Darmstadt, Germany) were performed after 2-3 days in vitro (DIV). Each coverslip was 
incubated with 0.5 µg total DNA and 0.5 µl Lipofectamine 2000, mixed in Neurobasal media, 
according to manufacturer’s instructions, for 2 h before being changed back to regular complete 
culturing media. Fixation of the neuronal cultures and immunocytochemistry was performed as 
described (Threadgill et al., 1997). 
2.2.3.2 Rabies virus and G-TVA construct 
The construct encoding for DsRedExpress2, the RABV glycoprotein (G) and the TVA800 (the GPI 
anchored form of the TVA receptor), designed as CAG-DsRedExpress2-2A-G-IRES2-TVA (i.e., 
G-TVA construct), as well as the construction of the G gene-deleted GFP-expressing RABV 
(SADΔG-GFP) have been described previously (Deshpande et al., 2013; Wickersham et al., 
2007a). Cells that express the G-TVA, as well as the SADΔG-GFP, synthesize the virus, which is 
able to transmit into all presynaptic neurons innervating the transfected neuron. This allows the 
identification of all neurons that synaptically connected to the transfected cell. 
2.2.3.3 Immunocytochemistry 
For immunocytochemistry, cells were fixed with 4% paraformaldehyde (PFA) in PBS, pH 7.4, 
for 10 min followed by blocking with 2% bovine serum albumin (BSA) and 0.2% Triton X-100 
in PBS for 30 min prior to staining. Primary antibodies were applied in blocking solution 
overnight at 4oC. One day later, cells were thoroughly washed in PBS and fluorescent-conjugated 
secondary antibodies were applied in blocking solution for 2 hours at RT. To visualize nuclei, 
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cells were incubated for 10 min in 0.1 µg/ml DAPI (Sigma). Cells on coverslips were embedded 
in Mowiol mounting medium (Roth, Karlsruhe, Germany) and allowed to dry at RT. 
2.2.3.4 Time lapse video microscopy 
Time-lapse video microscopy of dissociated cultures from the embryonic cerebral cortex at E14 
was performed with an AxioObserver Z1 (Zeiss, Oberkochen, Germany) at a constant 
temperature of 37oC and 8% CO2. Phase contrast images were acquired every 10 min and 
fluorescent images every 20 min for 8-9 hours using a 20x objective (Zeiss), an AxioCamHRm 
camera and a Zeiss AxioVision 4.7 software. Single-neurite tracing was performed in ImageJ 
using the Simple Neurite Tracer plugin (Longair et al., 2011). Movies were assembled using 
ImageJ 1.42q (National Institute of Health, USA) software with 1 frame per second.   
2.2.4 Animals 
Animals were anaesthetized by intraperitoneal injection of a solution containing 1.0 mL 
Ketamine hydrochloride, 10% (injected approximately 100mg/kg body weight), 0.25 ml 2% 
Xylazine hydrochloride (Rompun; injected at 5 mg/kg body weight) and 2.5 ml physiological 
saline solution (sodium chloride). A lethal dose is required to ensure that mice are sedated during 
perfusion. Per adult mouse about 200-250 µl Ketamine/Rompun was injected. To ensure the 
mouse was properly sedated after injection, the toes were pinched to determine the mouse’s 
response to a painful stimulus.  
Anaesthetized animals were subsequently transcardially perfused, first with 1x PBS for 2-3 min 
and then with 4% PFA for 18-23 min. Brains were dissected and post-fixed in 4% PFA for 10 -
15 min, thoroughly washed with 1x PBS and stored in 1x PBS at 4oC till sectioning. For 
histology, fixed brains were cryoprotected in 30% sucrose (in PBS), embedded in tissue-tek 
(OCT compound) and stored at -20oC. Thirty µm free-floating cryostat sections were stored in 
cryo-protectant solution at -20oC. 
For immunohistochemistry, sections were blocked with 5% goat serum and 0.5% Triton X-100 
in PBS for 30 min prior to staining. Primary antibodies were applied in blocking solution 
overnight at 4oC. The day after, sections were thoroughly washed in PBS and secondary 
antibodies conjugated to fluorescent dyes or biotin, were applied in blocking solution for 2 hours 
at RT. For biotinylated antibodies incubation with streptavidin linked to Alexa dyes followed. 
To visualize nuclei, cells were incubated for 10 min in 0.1 µg/ml DAPI (Sigma). Sections were 
embedded in Mowiol mounting medium (Roth) and allowed to dry at RT. Slides were stored at 
4oC in boxes.   
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2.2.5 Image collection and quantitative analysis 
2.2.5.1 Confocal imaging 
Stainings were imaged using either a LSM10 (Zeiss) or a SP5 (Leica) laser-scanning confocal 
microscope. For overview pictures of whole brain sections the Zeiss AxioImager.M2 fluorescence 
microscope was used. High quality pictures (1024x1024 or 2048x2048 pixels) were taken using a 
25x or 40x objective. Serial z-stacks were taken and collapsed to obtain a maximum-intensity 
projection of the scanned image. Laser power levels, photomultiplier gain levels, scanning speed, 
and the confocal pinhole size were kept constant within experimental and control specimens. 
Data were saved as .lsm or .lif files so that all information could be saved. For further processing 
pictures were exported as tiff files. Digital processing of entire images, including adjustment of 
brightness and contrast, was performed using Photoshop CS3 (Adobe, Munich, Germany). 
High-resolution z-stacks of dendrites from cortical and hippocampal neurons were collected with 
the 40x lens and a 2x digital zoom factor (optical sections of 0.5-1 µm). The number of primary 
dendrites emerging from the soma was manually counted and the dendritic length in µm was 
determined using the Zen2009 software (Zeiss, Oberkochen, Germany) in cortical and 
hippocampal neurons after 10 DIV using the images obtained with the laser-scanning confocal 
microscope as detailed above. Spine density was manually determined in 20 µm long dendritic 
segments. Bassoon and PSD95 puncta were also manually determined. 
The number of presynaptic partners of double transduced cells (GFP+/DsRED+) was 
determined by counting the double transduced cells (GFP+/DsRED+) and the RABV-only single 
transduced cells (GFP+). Results were expressed as connectivity ratio, representing the number of 
GFP-positive cells per GFP- and DsRed-double positive cells as described by (Wickersham et al., 
2007).	
2.2.5.2 Statistical analysis 
Results are presented as means ± SD. Statistical significance was calculated with GraphPad Prism 
5 (GraphPad Software, San Diego, California) using the One-way ANOVA test with Dunnett’s 
posthoc test. For the experiments with the rabies virus we used the unpaired t-test with Welch’s 
correction. A p level of <0.05 was set as the level of statistical significance. 
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3 Results 
3.1  Antibodies against LRP4 
The distribution of the LRP4 protein in the CNS is unknown. In order to analyze the 
distribution of LRP4 in the CNS, I generated two polyclonal antibodies in rabbits. These 
antibodies together with two commercially available antibodies (see Materials and Methods 
section for details) were used throughout my study to determine the distribution and localization 
of LRP4. To generate antibodies against LRP4 a unique sequence of the protein was identified. 
Based on previous studies (Tian et al., 2006), two regions of the LRP4 protein were selected as 
antigens, an intracellular and an extracellular region, respectively. Additionally, to exclude 
possible cross-reactions of the antibodies with other proteins (in particular with other members 
of the LDL family) due to sequence similarities, a BlastP database search was performed. Two 
possible regions were selected as antigens: sequence 1 (intracellular part of the protein, amino 
acids: 1755-1905) with the length of 150 amino acids 
(DPGMGNLTYSNPSYRTSTQEVKLEAAPKPAVYNQLCYKKEGGPDHSYTKEKIKIVEGI
RLLAGDDAEWGDLKQLRSSRGGLLRDHVCMKTDTVSIQASSGSLDDTETEQLLQEEQ
SECSSVHTAATPERRGSLPDTGWKHERKLSSESQV) and sequence 2 (juxtamembrane 
extracellular part of the protein, amino acids: 1383-1700) with the length of 317 amino acids 
(LNNVISLDYDSVHGKVYYTDVFLDVIRRADLNGSNMETVIGHGLKTTDGLAVDWVA
RNLYWTDTGRNTIEASRLDGSCRKVLINNSLDEPRAIAVFPRKGYLFWTDWGHIAKIE
RANLDGSERKVLINTDLGWPNGLTLDYDTRRIYWVDAHLDRIESADLNGKLRQVLVS
HVSHPFALTQQDRWIYWTDWQTKSIQRVDKYSGRNKETVLANVEGLMDIIVVSPQR
QTGTNACGVNNGGCTHLCFARASDFVCACPDEPDGHPCSLVPGLVPPAPRATSMNE
KSPVLPNTLPTTLHSSTTKTRTSLEGAGGRCSER). Antibodies raised in rabbit were ordered 
from Pineda Antikörper Service, Berlin, Germany. For each sequence, serum of the animal was 
collected after three immunizations. IgGs were affinity-purified from the rabbit sera using the 
antigen in an affinity column method. To determine the selectivity and specificity of the anti-
LRP4 antibodies, a selective staining pattern, the disappearance of staining after preabsorption of 
the antiserum with the purified corresponding antigen and a protein band of the expected size on 
Western blots are required. The criteria for the specificity of the antiserum include the absence of 
staining in mice that are deficient for the protein of interest, an identical staining pattern of 
antibodies raised against different epitopes on the same protein (not true if the protein is cleaved 
for example) and the correspondence between the staining pattern after in situ hybridization 
(ISH) and immunohistochemistry (IHC) in consecutive sections (Pradidarcheep et al., 2008). 
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Figure 3.1. Determination of antibody 
specificity using HEK293 cells 
transiently transfected with full-length 
LRP4 
Construct for overexpression of full-length LRP4 
in HEK293 cells. Immunocytochemistry of 
HEK293 cells transiently transfected with 
pCMV-LRP4-IRES-GFP. Cells were fixed two 
days post transfection. (A-D) The transfected 
cells can be distinguished by GFP staining (green 
channel). (A’-D’) Single channel images 
depicting the transfected cells stained for LRP4 
(red channel) using the commercial antibody 
against the intracellular epitope (A’), the 
commercial antibody against the extracellular 
epitope (B’), the generated-in-house antibody 
against the intracellular epitope (C’), and the 
generated-in-house antibody against the 
extracellular epitope (D’). Note that all 
antibodies detect LRP4. (A”-D”) Merged images 
of the single channel images. Nuclei stained for 
DAPI (blue channel). Scale bar: 20 µm. 
 
3.1.1 Immunocytochemistry of HEK293 cells 
As a first step to test the specificity/selectivity of the anti-LRP4 antibodies, I transiently 
overexpressed the full-length and the extracellular part of LRP4 in HEK293 cells. To this end, I 
cloned the LRP4 cDNA encoding the full-length protein into the pMES vector (Schröder et al., 
2007), which contains an internal ribosomal entry site (IRES) sequence followed by the cDNA 
coding for eGFP (pCMV-LRP4-IRES-eGFP). The simultaneous expression of LRP4 and eGFP 
(due to the IRES sequence) allowed me to distinguish transfected from untransfected cells.  
To overexpress specifically extracellular LRP4, the cDNA encoding the extracellular part of the 
protein was cloned into pEXPR-IBA42 vector under the CMV promoter generating the pCMV-
LRP4ext vector. I co-transfected HEK293 cells with the pCMV-LRP4ext and a second vector 
encoding a CAG-driven eGFP protein, which allowed me to identify the transfected cells 
(pCAG-GFP+). I confirmed the presence of LRP4 in the transfected HEK293 cells using 
antibodies against LRP4 and GFP (Figure 3.1 and Figure 3.2). All of the antibodies selectively 
stained the HEK293 cells that were transfected with the full-length LRP4, but not untransfected 
cells (Figure 3.1). Immunocytochemistry of unfixed cells confirmed the presence of LRP4 on the 
cell surface and in the cytoplasm. The staining observed in the cytoplasm can be explained by the 
presence of LRP4 in the Golgi apparatus and the endoplasmic reticulum. 
 
		
 
Results 
 
  
45 
Figure 3.2. Determination of antibody 
specificity using HEK293 cells 
transiently transfected with extracellular 
LRP4 
Constructs for the simultaneous expression of 
GFP and extracellular LRP4 in HEK293 cells. 
Immunocytochemistry of HEK293 cells 
transiently cotransfected with pCMV-LRP4ext 
and pCAG-GFP as a reporter. (A-D) The 
transfected cells can be distinguished by GFP 
staining (green channel). (A’-D’) Single channel 
images depicting the transfected cells stained for 
LRP4 (red channel) using the commercial 
antibody against the intracellular epitope (A’), 
the commercial antibody against the 
extracellular epitope (B’), the generated-in-house 
antibody against the intracellular epitope (C’), 
and the generated-in-house antibody against the 
extracellular epitope (D’). Note that none of the 
antibodies directed against the intracellular epitope detect the extracellular part of LRP4. (A”-D”) Merged 
images of the single channel images. Scale bar: 20 µm. 
 
Moreover, only the antibodies directed against the extracellular region of LRP4 stained HEK293 
cells that were cotransfected with the pCMV-LRP4ext and the pCAG-GFP (Figure 3.2). These 
results show that the antibodies against both the intracellular and the extracellular epitopes 
selectively detect LRP4 in HEK293 cells that express LRP4.  
3.1.2 Western blotting 
To further test the specificity of the antibodies, SDS-PAGE followed by Western blotting was 
performed. The samples included protein lysates from transfected and untransfected HEK cells. 
Samples were separated on SDS-PAGE gels and analyzed by Western blotting. I detected a 250 
kDa band (Figure 3.3) representing the expected size of the LRP4 protein after posttranslational 
modifications (Tian et al., 2006). However, transfection of LRP4 revealed different protein 
products at approximately 70-90 kDa, in addition to the 250 kDa full-length LRP4 band. These 
smaller bands might be processing products of the receptor, since there is evidence for proteolytic 
cleavage of LRP4 by ADAM10 and γ-secretase (Dietrich et al., 2010). There was no detectable 
signal in lysates from untransfected HEK cells. In addition, the pre-immune sera from both 
rabbits used at equivalent dilutions detected no band in LRP4-transfected HEK cells (data not 
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shown). These results further demonstrate the specificity of the antibodies. More Western 
blotting results will follow at later paragraphs showing the specificity of the antibodies also in 
different tissues.  
	
Figure 3.3. Analysis of antibody specificity in Western blotting 
SDS-PAGE analysis and Western blot detection of HEK cells transfected with three different plasmids for 
overexpression of LRP4. The green arrows indicate the location of LRP4 at 250 kDa. Note that no signal 
can be detected in untransfected HEK cells. Samples from left to right are: lane M, molecular weight 
marker; lane 1, HEK cells transfected with empty vector; lane 2, HEK cells transfected with full-length 
human LRP4; lanes 3 and 4, HEK cells transfected with full-length mouse LRP4. The antibodies used are: 
the antibody generated-in-house against the intracellular epitope (A); the commercial antibody against the 
intracellular epitope (B); the antibody generated-in-house against the extracellular epitope (C); the 
commercial antibody against the extracellular epitope (D). Note the equivalent staining patterns with all 
four antibodies. 
3.1.3 Immunohistochemistry of the NMJ 
To further validate the ability of the antibodies to specifically detect LRP4 in tissue, I stained 
adult mouse skeletal muscle where it has previously been reported that LRP4 immunoreactivity is 
concentrated at the neuromuscular junction (Kim et al., 2008; Zhang et al., 2008). To this end, 
longitudinal sections of adult mouse leg muscles were double-labeled for AChRs using α-
bungarotoxin (selectively labeling the NMJ) and for LRP4. As a positive control, NMJs were 
stained for agrin and AChRs. As expected, the staining with the pre-immune sera was negative 
(data not shown). I confirmed using all four anti-LRP4 antibodies that in adult mouse skeletal 
muscle LRP4 was concentrated at the NMJ where it colocalized with the AChRs (Figure 3.4).  
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Figure 3.4. Analysis of LRP4 localization at the adult NMJ and antibody specificity 
(A-D) Longitudinal sections of the adult mouse muscle stained with α-bungarotoxin (red channel), a toxin 
that specifically binds to the AChR alpha1 subunit and thus labels the NMJ. (A’-D’) Single channel images 
depicting the same NMJs stained for LRP4 (green channel) using the commercial antibody against the 
intracellular epitope (A’), the commercial against the extracellular epitope (B’), the generated-in-house 
antibody against the intracellular epitope (C’), and the generated-in-house against the extracellular epitope 
(D’). Note that all the antibodies detect LRP4 at the NMJ. The arrowheads in (A’) indicate the motor 
neurons that are also positive for LRP4 but only the commercial antibody against the intracellular epitope 
can label them. α-BTX: α-bungarotoxin. Scale bar: 20 µm. 
 
To further rule out non-specific immunostaining signals, I performed an antibody-antigen 
competition experiment. To this end, the peptides against which the antibodies were raised were 
preincubated with the respective antibodies. This antibody-peptide mixture was then applied to 
cryostat sections from adult mouse skeletal muscle. Preabsorption process with the immunogen 
efficiently eliminated the staining of the NMJs demonstrating that the antibodies specifically 
recognized LRP4 (Figure 3.5). 
 
Figure 3.5. Test of antibody specificity – 
antibody antigen competition 
experiment  
(A-B’) Longitudinal sections of adult mouse 
skeletal muscle stained with α-bungarotoxin (red 
channel; A and B) and with either LRP4 
antibody against the intracellular epitope (green 
channel; A’) or with LRP4 antibody pre-
incubated with the peptide the antibody was 
raised against (green channel; B’). Note that 
staining with the LRP4 antibody specifically 
labeled the NMJ (A’), whereas the staining 
pattern is abolished when the antibody is pre-
incubated with the peptide (B’). Thus, 
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preabsorption with the peptide was able to compete with the signal of immunostaining. Note that other 
antibody staining was likewise abolished in the presence of the peptide used as immunogen. Scale bar: 20 
µm. 
 
These results confirm that the antibodies can specifically detect LRP4 in adult murine NMJs and 
can be used to analyze the distribution of LRP4 in other tissues, especially the brain. 
3.2  LRP4 expression and localization in the adult murine brain 
3.2.1 Reverse transcription PCR 
After having confirmed the specificity and selectivity of the antibodies, I used them to determine 
the distribution of LRP4 in the CNS. To initially test whether LRP4 is expressed in the 
developing and adult murine CNS, I performed reverse transcription PCR. Specifically, total 
RNA was isolated from brain and eyes of four developmental stages (P5, P8, P15 and adult). As a 
positive control for the presence of lrp4 mRNA, cDNA from adult brain was used since it has 
been previously reported that lrp4 is expressed in the adult rat brain by in situ hybridization 
(Tian et al., 2006). As expected, no band was detected in the control reaction where water was 
used as a template. I detected lrp4 mRNA in brain and eyes of the adult and of developmental 
stages (Figure 3.6), suggesting that LRP4 transcripts are present in the CNS before, during and 
after synaptogenesis which occurs between postnatal days 8-15. 
 
	
Figure 3.6. lrp4 mRNA is present in the murine brain and eyes during development and 
in adult stages 
Reverse transcription PCR of cDNA from mouse brain and eyes of different developmental stages using a 
set of intron/exon spanning primers. lrp4 mRNA can be detected in the brain and eyes of P5, P8, P15 and 
adult mice. The size of the band is the size of the PCR product based on the designed primers. Note that 
no band can be detected in the reaction where water was used as a template (negative control). 
3.2.2 Western blotting 
To address if LRP4 protein can be detected in the adult mouse brain, I performed Western 
blotting using lysates from the adult brain. To this end, membrane protein fractions from the 
cerebral cortex, hippocampus, cerebellum and olfactory bulb were prepared and separated on 
SDS-PAGE gel and subsequently analyzed by Western blotting. A band with a molecular mass of 
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approximately 250 kDa was detected in all tissues (Figure 3.7). As a positive control, lysates 
from HEK cells transfected with the full-length LRP4 were used. I did not detect a specific signal 
in lysates from the untransfected HEK cells (Figure 3.3), demonstrating the specificity of the 
antibodies in Western blotting. These results show that LRP4 can be detected in the adult 
murine brain, not only at the mRNA, but also at the protein level.  
	
Figure 3.7. LRP4 protein is present in the adult mouse brain 
Western blotting of protein lysates (1 µg of protein) from the adult mouse cerebral cortex (Cx), 
hippocampus (Hip), cerebellum (Cb) and olfactory bulb (OB) probed with anti-LRP4 antibodies. Lysates 
from HEK cells transfected with full-length mouse LRP4 (+ control) and untransfected HEK cells (- 
control) were used to determine the specificity of the antisera. Anti-α-tubulin antibodies were used as 
loading control. The antibodies reacted with a band of 250 kDa, corresponding to the molecular mass of 
LRP4. 
3.2.3 Immunohistochemistry 
Previous studies have shown that lrp4 mRNA is expressed in the adult rat brain, including the 
neocortical and hippocampal areas, the neurogenic niches, the olfactory bulb (OB) and the 
cerebellum (Tian et al., 2006). In order to characterize the distribution of LRP4 protein in the 
adult mouse brain, I performed immunohistochemical analyses using both the commercially 
available and the generated in-house antibodies. All antibodies exhibited a similar if not identical 
distribution pattern in all the brain areas tested, but the commercial antibodies had a lower 
background. For this reason, the distribution of LRP4 is described in the following sections using 
the commercial antibody against the intracellular epitope.  
3.2.3.1 Cerebral cortex 
To determine the cellular and subcellular localization of LRP4 in the adult mouse cortex I 
performed immunohistochemical analysis. The staining revealed a wide distribution of LRP4 
throughout the sub-cortical areas – motor, somatosensory and visual cortex (Figure 3.8). Double 
labeling with NeuN, which is a specific marker for postmitotic neurons (Mullen et al., 1992), 
revealed that LRP4 is localized in most, if not all, postmitotic (i.e. NeuN-positive) neurons in all 
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cortical layers (I-VI), particularly in neuronal cell bodies and dendrites, as well as in axons 
(Figure 3.8). 
	
Figure 3.8. Distribution of LRP4 in the neurons of the adult murine cortex 
(A) Overview of NeuN (red channel) and LRP4 (green channel) distribution in a sagittal reconstruction of 
the adult murine cerebral cortex. (B) Confocal z-stack of adult somatosensory cortex. (a’-d’’’) Insets depict 
the boxed areas from panel B, representing high magnifications of different layers of the cortex. The 
different cortical layers are indicated on the right side of the merged picture. Note that LRP4 is associated 
with the cell bodies and processes of neurons of all cortical layers (layer I/II a’-a’’’; layer III/IV b’-b’’’; layer 
V c’-c’’’; layer VI d’-d’’’). VIS: visual cortex; SS: somatosensory cortex; MO: motor cortex. Scale bars: 500 
µm (A), 100 µm (B), and 50 µm (insets in B).  
	
To further examine whether the distribution of LRP4 in the cortex is restricted to neurons or if it 
is also present in the astroglial population, I immunolabeled adult mouse cerebral cortex with 
antibodies against GFAP/S100β, which are specific astrocytic markers (Jacque et al., 1978; Walz, 
2000), and against LRP4. This analysis revealed that the levels of LRP4 protein were below the 
detection limits in astrocytes of the adult mouse cerebral cortex (Figure 3.9)  
In summary, these results demonstrate that little, if any, LRP4 protein is present in astroglial 
cells, but high expression is detectable in neurons within all layers of the adult cortex. 
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Figure 3.9. Distribution of LRP4 in astrocytes of the adult murine cortex 
(A) Maximum projection of 10 confocal planes of the adult cerebral cortex labeled for LRP4 (green 
channel), GFAP and S100β (red channel). Nuclei were labeled with DAPI (blue channel). Enlarged single 
confocal planes of the boxed area depicting an astrocyte (arrowhead in a’) surrounded by a number of 
neurons (arrows in a’). While the neuronal cell bodies appear strongly labeled by anti-LRP4 antibodies 
(arrows in a”), the levels of LRP4 in the astrocyte appear much lower and are close to the detection limits 
(arrowhead in a”). Scale bars: 100 µm (A), 20 µm (a’ and a”). 
3.2.3.2 Hippocampus 
Staining of the adult murine hippocampus with the anti-LRP4 antibody revealed a widespread 
distribution of LRP4 within the hippocampus, with higher expression levels in the CA1, CA2 
and CA3 regions and lower levels in the dentate gyrus (DG; Figure 3.10). Double labeling with 
anti-NeuN antibody showed that LRP4 is highly concentrated in hippocampal neurons of the 
CA1, CA2 and CA3 regions particularly around their soma and in their processes (Figure 3.10). 
In addition, LRP4 was highly concentrated in the axons of the entorhinal cortical neurons which 
give rise to the perforant path and project to the dentate gyrus and the hippocampal fields CA1 
and CA3. In contrast to what has been reported (Tian et al., 2006), only low levels of LRP4 
protein were detected in the dentate gyrus compared to the CA1-CA3 hippocampal regions. 
Furthermore, double labeling with anti-Doublecortin (Dcx) antibody, that specifically marks 
newly generated neurons, revealed that in adult-born, Dcx-positive cells the levels of LRP4 
protein were below the detection limits (Figure 3.10). 
Taken together, these data indicate that in the adult murine hippocampus LRP4 is 
predominantly localized in neurons of the CA1-CA3 regions, and at lower levels in the granule 
cells of the dentate gyrus, excluding the adult-born cells. The differential levels of LRP4 
expression in the dentate gyrus compared to the CA1-CA3 region might suggest that LRP4 is 
primarily expressed in neurons generated during embryonic and early postnatal stages. 
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Figure 3.10. Distribution of LRP4 in the adult murine hippocampus 
(A-A”) Reconstruction of a sagittal confocal section of the adult hippocampus labeled for LRP4 (green 
channel), Dcx (red channel) and NeuN (blue channel). (a-c) Panels that represent high magnifications of 
single confocal sections and panel d is a maximum projection of 12 confocal planes of the areas indicated 
by white boxes in panel A”. Note the presence of LRP4 in somas and processes of hippocampal neurons of 
the CA1- (inset b) and CA3- (insets a and c) regions and in the axons of the perforant path (inset d). Note 
that the Dcx-positive cells of the dentate gyrus (c, inset with two asterisks) are not labeled by anti-LRP4 
antibodies. Scale bars: 100 µm (A”), and 50 µm (insets). 
3.2.3.3 LRP4 localization in the adult-born neurons 
To more directly investigate if LRP4 is expressed by neurons recently generated during adult 
neurogenesis, I used a transgenic mouse line in which GFP expression can be induced in adult 
neural stem cells from the dentate gyrus and subependymal zone (SEZ) (GLAST::CreERT2/eGFP; 
Mori et al., 2006; Nakamura et al., 2006) and is subsequently inherited by their progeny. In this 
mouse line the tamoxifen inducible form of Cre recombinase (CreERT2) is expressed in the locus 
of the astroglia/astrocyte-specific glutamate transporter (GLAST) and tamoxifen administration 
can induce the Cre-mediated recombination of the reporter locus (eGFP). GFP expression is 
induced in astroglia, including cells with astroglial features in the lateral wall of the lateral 
ventricle (LV), the subependymal zone, as well as in the subgranular layer (SGL) of the dentate 
		
 
Results 
 
  
53 
gyrus and is maintained also in their neuronal progeny. Forty-five days after tamoxifen-induced 
transgene expression, neither the recombined newly generated neurons (GFP+ Dcx+) nor the 
recombined mature neurons (GFP+ Dcx-) could be labeled with anti-LRP4 antibodies, 
confirming the very low levels of LRP4 protein in the granule neurons of the dentate gyrus 
(Figure 3.11). In agreement with the results described by Burk et al. (2012), recombined (GFP+) 
neuroblasts and postmitotic neurons that were generated in the SEZ and migrated to the 
olfactory bulb along the rostral migratory stream were also not labeled by anti-LRP4 antibodies, 
confirming that neurons generated during adult neurogenesis initially do not express LRP4 
(Figure 3.11). 
Taken together, these results demonstrate that little, if any, LRP4 protein is present in adult-
born neurons, but high expression is detectable in a subpopulation of neurons of the olfactory 
bulb.   
	
Figure 3.11. Overview of LRP4 distribution in the adult-born neurons 
(A-A’) Reconstruction of a sagittal confocal section of the adult hippocampus of the 
GLAST::CreERT2/eGFP transgenic mouse line labeled for LRP4 (red channel) and GFP to label the 
recombined cells (green channel). Nuclei are labeled with DAPI (blue channel). (a-c) Panels that represent 
high magnifications of the areas indicated by white boxes in panel A’. (a-a’) Enlarged image of the DG. 
Note the absence of LRP4 in the DCX-labeled (blue channel) newly generated neurons of the DG (a, a’). 
Note also the absence of LRP4 immunoreactivity in the newly generated neurons that are not DCX-
labeled (i.e. are more mature; white boxed area with one asterisk, white arrow). (b) Enlarged image of the 
SEZ. Note the absence of LRP4 immunoreactivity in the adult-born generated cells (white boxed area with 
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one asterisk, white arrows). (c) Enlarged image of the OB. GFP-recombined neurons do not show 
immunoreactivity for LRP4 (white boxed areas with one and two asterisks, white arrows). However, in the 
OB, the mitral cells are immunoreactive for LRP4 (white boxed area with two asterisks, white arrowhead). 
DG: Dentate gyrus; DCX: Doublecortin; SVZ: Subventricular zone; OB: Olfactory bulb. Scale bars: 500 
µm (A’), 100 µm (a; b; c), 50 µm (panels with asterisks). 
3.2.3.4 Cerebellum 
To determine the distribution of LRP4 in the cerebellum, I immunolabeled cryostat sections 
from adult mouse cerebellum with antibodies against calbindin D28k, which is a specific marker 
for mature Purkinje neurons (Jande et al., 1981), NeuN and GFAP (Figure 3.12). Double 
staining with anti-LRP4 antibody revealed that in the cerebellum LRP4 was exclusively localized 
in calbindin-positive Purkinje cells, particularly in their cell bodies and primary, secondary and 
tertiary dendrites. Hardly any NeuN-positive cells in the granule cell layer showed expression of 
LRP4, indicating a distribution of LRP4 in specific subsets of neurons in this area of the CNS. 
Double staining using antibodies against neurofilament heavy, a specific marker for neuronal 
axons, and LRP4 revealed that in addition to the cell bodies and dendrites LRP4 was also present 
in axons extending from the Purkinje neurons (Figure 3.12 E-E’’’).     
To examine if LRP4 was present in the Bergmann glia of the cerebellum, I immunolabeled adult 
mouse cerebellum with antibodies against GFAP. Double labeling revealed that in this specific 
glial population of the cerebellum the level of LRP4 protein was below the detection limits 
(Figure 3.12 D-D’’’). 
Taken together, these results show that in the adult mouse cerebellum LRP4 is predominantly 
localized in Purkinje neurons. 
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Figure 3.12. Distribution of LRP4 in the adult murine cerebellum 
(A) Overview of LRP4 distribution in the adult murine cerebellum. Reconstruction of a sagittal section 
using Zeiss LSM710 “ZEN-tilescan”. (B-E’’’) Sagittal sections of single folia of the adult cerebellum 
labeled with antibodies against LRP4 (green channel; B’, C’, D’ and E’) and calbindin D28k (red channel; 
B”), NeuN (red channel; C”), GFAP (red channel; D”) or Neurofilament heavy (red channel; E”). Nuclei 
were labeled with DAPI (blue channel). Note the colocalization of LRP4 immunoreactivity with the 
Purkinje neuron-specific marker calbindin. Scale bars: 500 µm (A), 100 µm (B-E’’’) and 50 µm (insets). 
3.3  LRP4 distribution in neuronal cultures 
As a first step to investigate the function of LRP4 in the CNS I used cultures of hippocampus 
and cortex. Low-density cultures are far less complex than neural tissue, making them an ideal 
model for investigating the subcellular localization and trafficking of neuronal proteins (Kaech 
and Banker, 2006). Moreover, these cultures are suitable for the overexpression and knockdown 
of proteins, allowing the functional analysis of proteins by interfering with their concentration. 
To determine the spatial and temporal localization of LRP4, I immunolabeled dissociated cells 
from the embryonic cerebral cortex and hippocampus at different time points (days) in vitro 
(DIV3, 6, 8, 10 and 12) with the same anti-LRP4 antibody previously used for the detection of 
LRP4 in vivo and in combination with antibodies against the microtubule associated protein 
(MAP2) that localizes to the soma and the dendrites (Caceres et al., 1984). I detected LRP4 in 
cortical neurons of all stages analyzed (Figure 3.13). Similar results were obtained in cultured 
hippocampal neurons (Figure 3.13). These results show that LRP4 is expressed in both cortical 
and hippocampal neurons at all stages analyzed. 
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Figure 3.13. Endogenous LRP4 expression in dissociated cultures from the embryonic 
cerebral cortex and hippocampus 
Dissociated cells from the E14 cortex (A) and E16 hippocampus (B) at different days in vitro (DIV) 
labeled for LRP4 (red) and MAP2 (green). Note that LRP4 is present in neurons of all the stages analyzed 
(DIV3, 6, 8, 10 and 12). Scale bars: 100 µm (A; B). 
3.3.1 LRP4 is localized in somas, dendrites and axons of cultured hippocampal 
neurons 
In order to more precisely determine the subcellular distribution of LRP4, I stained dissociated 
cells from the E16 hippocampus with antibodies that specifically label either the dendritic or the 
axonal processes of neurons. To this end, hippocampal neurons were cultured in vitro until day 
12 (DIV12) and stained for MAP2 and the axonal marker, Tau. I observed abundant, punctate 
LRP4 staining on the neuronal cell bodies and the proximal, MAP2-positive dendrites. Some 
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punctate staining was also evident on Tau-positive axons and growth cones at some distance 
from the cell body (Figure 3.14). 
	
Figure 3.14. Distribution of LRP4 in hippocampal neuronal cultures 
(A-A’) E16 hippocampal neurons cultured for two weeks. Immunostaining for MAP2 (green), Tau (red) 
and LRP4 (white). Scale bar 50 µm. (a-d’) Enlarged images of the cells in pictures A and A’ (white boxed 
areas). (b-b’) MAP2 labeled dendrites are positive for LRP4 (white arrows) and Tau labeled axons are also 
positive for LRP4 (white arrowheads). (c-c’) Tau-labeled growth cones show LRP4 immunoreactivity 
(white arrows). (d-d’) Neuronal cell bodies also show immunoreactivity for LRP4. Scale bar 20 µm.    
 
The presence of LRP4 in neurons in vitro was confirmed by Western blotting using protein 
lysates from dissociated cortical and hippocampal cultures in which the full-length 250 kDa band 
was detected (Figure 3.15). 
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Figure 3.15. LRP4 protein is present in lysates from cortical and hippocampal neurons 
Western blotting of protein lysates from cortical (Cx) and hippocampal (Hip) neurons of DIV1 probed 
with anti-LRP4 antibodies. Lysates from HEK293 cells transfected with full-length mouse LRP4 (+ 
control) and untransfected HEK293 cells (- control) were used to determine the specificity of the antisera. 
Anti-α-tubulin antibodies were used as loading control. The antibodies reacted with a band of 250 kDa, 
corresponding to the molecular mass of LRP4. 
 
These results are in agreement with the distribution of LRP4 in the hippocampus of adult mouse 
brain tissue where LRP4 is localized in somas and processes of hippocampal neurons of the CA1-
CA3 regions (Figure 3.10). 
3.3.2 Both glutamatergic and GABAergic neurons express LRP4 
To determine if LRP4 is present in both glutamatergic and GABAergic neurons I 
immunolabeled hippocampal neurons with antibodies specific for these neuronal subtypes. Thus, 
glutamatergic neurons were labeled with CamKII, a well-established marker for glutamatergic 
neurons (Jones et al., 1994), whereas GABAergic neurons were identified by an antibody against 
GABA (Sloviter and Nilaver, 1987). I detected LRP4 in both neuronal types (Figure 3.16), 
suggesting that it might be involved in the development of both excitatory and inhibitory 
neurons. 
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Figure 3.16. LRP4 is present in both glutamatergic and GABAergic neurons 
(A-A”) E16 hippocampal neurons fixed after 17 days in culture. Immunostaining for MAP2 (green 
channel) and LRP4 (red channel). Nuclei are stained with DAPI (blue channel). Note that all the MAP2-
labeled cells are immunoreactive for LRP4. (B-B”) E16 hippocampal neurons after 17 days in culture. 
Immunostaining for CamKII (green channel), LRP4 (red channel) and DAPI nuclear staining (blue 
channel). Note that LRP4 is expressed in CamKII positive neurons (white arrows). However, not all 
LRP4-labeled cells are positive for CamKII (white arrowhead). (C-C”) E16 hippocampal neurons after 17 
days in culture. Immunostaining for GABA (green channel), LRP4 (red channel) and DAPI nuclear 
staining (blue channel). GABA positive neurons are immunoreactive for LRP4 (white arrow). Scale bars: 
50 µm. 
3.3.3 LRP4 in astrocytes 
To verify the results obtained from the immunostaining performed in the adult mouse cortex 
where I showed that the levels of LRP4 in astrocytes were below the detection limits (Figure 
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3.9), I co-immunostained hippocampal cultures with antibodies against GFAP, βIII-tubulin and 
LRP4. As expected, βIII-tubulin positive neurons showed high levels of LRP4 in both their 
somas and processes (Figure 3.17). In contrast, LRP4 levels in GFAP-labeled astrocytes were 
below the detection limits (Figure 3.17). These results show that in these cultures LRP4 is 
mainly expressed by neurons rather than glial cells, confirming my previous in vivo results.  
	
Figure 3.17. LRP4 is present in astrocytes in low levels 
(A) Dissociated cells from the E16 hippocampus after 8 DIV labeled for βIII-tubulin (red channel), GFAP 
(green channel) and LRP4 (white channel). Note that LRP4 is highly expressed in βIII-tubulin positive 
neurons (arrows in a’ and b’), whereas LRP4 levels in GFAP positive astrocytes are close to the limits of 
detection (arrowhead in b’). Scale bars: 50 µm (A), 10 µm (a-b’). 
3.4  Function of LRP4 in neuronal cultures 
Previous studies have shown that at the NMJ muscle membrane-associated LRP4 was necessary 
and sufficient for presynaptic differentiation and the establishment of synaptic contacts between 
α-motoneurons and skeletal muscle fibers (Wu et al., 2012; Yumoto et al., 2012; Kim et al., 
2008). To investigate the function of LRP4 in neuronal cultures, I performed in vitro gain- and 
loss-of-function experiments and analyzed their effects on synaptogenesis and dendritic 
arborization. 
3.4.1 Overexpression of LRP4 in neurons 
To overexpress LRP4 in neuronal cultures of the cortex and the hippocampus, the full-length 
cDNA of mouse LRP4 was cloned into the pcDNA3.1(-) vector downstream the CMV 
promoter. In order to exclusively overexpress LRP4 in neurons I replaced the CMV promoter by 
the neuron-specific synapsin-1 (SYN) promoter, generating the plasmid pSYN-LRP4. Syn-1 is a 
phosphoprotein that regulates the formation of synaptic vesicles and has a high level of early 
transcription in primary hippocampal neurons (Kügler et al., 2001; Gascón et al., 2008). I co-
transfected cortical and hippocampal neurons on DIV3 with the pSYN-LRP4 plasmid and a 
second vector encoding a synapsin-driven eGFP-actin fusion protein (SYN-eGFP:actin), which 
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allowed me to observe spine-like protrusions enriched with GFP:actin monomers (Fischer et al., 
1998; Gascón et al., 2008). I next confirmed the presence of LRP4 protein in the co-transfected 
cells (eGFP:actin positive) by immunocytochemistry and observed exclusive expression in 
neurons (Figure 3.18). 
 
	
Figure 3.18. Constructs for expression of GFP:actin and LRP4 in neurons in vitro 
(A) Constructs encoding the GFP:actin fusion protein and for LRP4 ORF. Transgene expression is driven 
by the synapsin (SYN) promoter. (B) E14 cortical cultures transfected with either GFP:actin encoding 
plasmid (upper set of pictures) or double transfected with GFP:actin and LRP4 encoding plasmids (lower 
set of pictures). Immunostaining for eGFP (green channel) and LRP4 (red channle) reveals that in the case 
of the double transfection the neuron is transfected with both plasmids. Scale bars: 50 µm. 
3.4.2 Overexpression of LRP4 affects dendritic development and synapse 
formation in vitro 
The pSYN-LRP4 plasmid was used in order to overexpress LRP4 in cortical and hippocampal 
neurons. By using the transfection reagent Lipofectamine 2000 and only 0.5 µg of DNA a low 
efficiency of transfection was achieved that allowed me to analyze the morphological 
characteristics of individual neurons surrounded by non-transfected neurons. Interestingly, 
overexpression of LRP4 led to a prominent change of the dendritic morphology, i.e. an increased 
number of primary dendrites and a reduced length of the dendritic branches (Figure 3.19). 
Morphometric analysis revealed a significantly increased number of primary dendrites (13.87 ± 
B 
A 
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1.64 in cortical, p<0.01; 13.03 ± 1.32 in hippocampal, p<0.001) in neurons overexpressing 
LRP4 compared to the neurons transfected with the SYN-GFP:actin plasmid alone (7.54 ± 1.65 
in cortical; 6.39 ± 0.37 in hippocampal). I also observed a decreased primary dendritic length in 
both cortical and hippocampal neurons (49 ± 6.48 µm in cortical, p<0.001; 43.47 ± 10.64 µm in 
hippocampal, p<0.01) compared to control neurons (112 ± 10.26 µm in cortical; 133.1 ± 24.17 
µm in hippocampal). Thus, overexpression of LRP4 reduces the length of primary dendrites 
while increasing the number of dendritic branches in cortical and hippocampal neurons. I did 
not observe an effect of the LRP4 overexpression on the length and arborization of axonal 
processes extended by cortical and hippocampal neurons in culture (data not shown). 
 
 
Figure 3.19. LRP4 affects the number and length of dendrites and the number of spines 
in cultured cortical and hippocampal neurons 
Representative examples of dissociated cells from the E14 cerebral cortex after 10 DIV (A) and the E16 
hippocampus after 12 DIV (E) co-transfected with pSYN-GFP:actin and additionally with either pSYN-
LRP4 or with pCAG-miRLRP4 at DIV3. Enlarged images of dendritic segments are shown to illustrate 
the dendritic protrusions. Histograms depict the number of primary dendrites (B, F), the length of the 
primary dendrites (C, G) and the density of spines/protrusions (D, H) in cortical (upper panels) and 
hippocampal (lower panels) neurons. Note that overexpression of LRP4 significantly increased the number 
of primary dendrites (B, F; black bars) and the density of spines/protrusions (D, H; black bars) and 
decreases the dendritic length (C, D; black bars) in both cortical and hippocampal neurons. In contrast, 
knockdown of LRP4 significantly decreased the number of primary dendrites (B, F; red bars) and 
spines/protrusions (C, G; red bars) and significantly increased the dendritic length in cortical (C; red bar) 
but not in hippocampal (G; red bar) neurons. Data are shown as mean +/- SD from three independent 
experiments, n = 15-25 cortical neurons per condition/experiment; n = 5-10 hippocampal neurons per 
condition/experiment. *p<0.05, **p<0.01, ***p<0.001, One-way ANOVA with Dunnett’s posthoc test. 
Scale bars: 50 µm (A and E), and 10 µm (insets in A and E). 
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3.4.3 Time lapse analysis of E14 cortical neurons overexpressing LRP4 
Previous studies have demonstrated that at the NMJ LRP4 is required for the transformation of 
the highly motile growth cone to a much more stable presynaptic terminal (Wu et al., 2012; 
Yumoto et al., 2012). To investigate the mechanism of how LRP4 overexpression influenced 
dendritic arbor formation, I performed time-lapse video microscopy of neurons transfected with 
an RFP-encoding vector (pCAG-RFP) alone or in combination with the pSYN-LRP4 vector  
(Figure 3.20). Cells were transfected on DIV3 and imaging started 2-3 days after transfection 
and lasted for 8 hours. Following single dendrites from either control or LRP4 overexpressing 
cortical neurons over time, revealed that within a few hours after LRP4 overexpression, dendritic 
extension stopped (Figure 3.20). Neither extension nor retraction of dendritic processes was 
observed after LRP4 overexpression and the dendrites appeared rather immobile. This behavior 
might be similar to what has been reported for α-motoneurons at the NMJ, where LRP4 
expression arrested motor axon growth (Wu et al., 2012; Yumoto et al., 2012). Thus, my results 
suggest a similar role of LRP4 in process extension in α-motoneurons and in CNS dendrites. 
	
Figure 3.20. Overexpression of LRP4 in cultured cortical neurons reduced the dynamics 
of the primary dendrite growth 
(A) Fluorescence micrographs of representative examples of neurons from the E14 cerebral cortex (DIV5-
6) co-transfected with pCAG-RFP and pSYN-LRP4 or the empty pCAG-RFP control vector and live-
imaged for 8 hours two days after transfection. Red arrows indicate single dendritic processes followed over 
the imaging time. (B) Graphs representing the mobility of the two dendrites indicated by red arrows in 
panel A. The x axis represents the time in minutes and the y axis represents the length of each dendrite 
(2.016 pixels/µm). While dendrites of neurons transfected with the control vector were highly dynamic, 
overexpression of LRP4 resulted in a reduced motility and a stop of dendrite growth. (C) Overlay of the 
motility analysis of 35 (control) and 37 (overexpression) dendritic processes from 3 independent 
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experiments. Note that some dendrites decrease in length while the majority increases whereas after LRP4 
overexpression, neither shrinkage nor growth was observed. Scale bar: 50 µm (A). 
3.4.4 Overexpression of LRP4 increases the number of synapses 
To investigate if LRP4 levels affect the formation of synapse-like specializations, I first 
determined the density of dendritic protrusions in both cortical and hippocampal neurons 
overexpressing LRP4 and compared them to wildtype neurons (Figure 3.21). I observed an 
increase in the density of spine-like processes in hippocampal as well as in cortical cultures after 
neuron-specific overexpression of LRP4 (9.64 ± 0.46/ 20 µm in cortical, p<0.05; 16.64 ± 1.53/ 
20 µm in hippocampal neurons, p<0.001) compared to neurons transfected with pSYN-
GFP:actin (7.14 ± 0.53/ 20 µm in cortical; 9.74 ± 0.8/ 20 µm in hippocampal neurons). This 
increase in spine density was accompanied by a simultaneous increase in the number of puncta 
labeled by antibodies against presynaptic proteins, including bassoon (1.93 ± 0.54/µm in 
hippocampal, compared to 1.05 ± 0.04/µm in control cultures, p<0.05) and synaptobrevin2 
(SV2, 1.47 ± 0.42/µm in cortical, compared to 0.87 ± 0.02/µm in control cultures, p<0.05). 
Moreover, antibodies against the postsynaptic PSD95 protein showed a similar increase in 
puncta (1.1 ± 0.1/µm in hippocampal, compared to 0.66 ± 0.12/µm in control cultures, 
p<0.01). 
In summary, these results demonstrate that overexpression of LRP4, in addition to its effect on 
dendritic morphology, increases the density of spines and of synapse-like specializations in 
embryonic cortical and hippocampal neurons in vitro. 
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Figure 3.21. LRP4 affects the number of pre- and post-synaptic specializations in 
neuronal cultures. 
(A) Representative examples of dissociated cells from the E16 hippocampus co-transfected with pSYN-
GFP:actin and either pSYN-LRP4, pCAG-miRLRP4 or only the pSYN-GFP:actin as control. Enlarged 
images of single confocal planes of individual dendritic segments are shown. The dendrite was redrawn in 
red from the GFP signal in order to visualize the close association of the dendritic spine-like protrusions 
and the bassoon and PSD95 puncta, respectively. Note that changes in the expression levels of LRP4 
affected the number of pre- and post-synaptic puncta. The number of synapse-like specializations was only 
altered in the dendrites of the transfected neurons. The cropped areas show the synaptic specializations 
directly overlapping with the dendrite of the transfected cell (as indicated by the red line) without the 
synaptic specializations of the surrounding area (representing non-transfected neurons). This allowed 
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distinguishing the synaptic specializations directly associated with the dendrite of the transfected neurons 
from those of untransfected neurons and represents a more direct visualization of the number of synaptic 
specializations associated with a particular dendritic segment. Quantitative analysis of the number of 
bassoon (B) and PSD95 (C) puncta associated with the dendrites of hippocampal neurons and the number 
of synaptobrevin2 puncta (D) associated with the dendrites of cortical neurons revealed a significant 
increase of bassoon (B; black bar), PSD95 (C; black bar) and synaptobrevin2 (D; black bar) in all neurons 
after LRP4 overexpression. In contrast, knockdown of LRP4 led to a significant decrease in the number of 
bassoon (B; red bar) and synaptobrevin2 (D; red bar) puncta, without affecting the number of PSD95 
puncta (C; red bar). Data show mean +/- SD from three independent experiments; n = 5-7 cortical 
neurons per condition/experiment; n = 5-8 hippocampal neurons per condition/experiment. *p<0.05, 
**p<0.01, One-way ANOVA test with Dunnett’s posthoc test. Scale bar: 50 µm.   
3.4.5 Generation of microRNAs for the knockdown of LRP4 in vitro 
The experiments detailed above indicated that increased expression of LRP4 in cortical and 
hippocampal neurons promotes the formation of synapse-like specializations. However, this does 
not necessarily imply that basal endogenous levels of LRP4 are required for synaptogenesis. To 
analyze this, I examined the consequence of LRP4 loss-of-function. For this reason, I cloned four 
different microRNAs (mir1232, mir1544, mir6854 and mir7072; Figure 3.22) targeting the 
open reading frame (ORF) or the 3’ UTR of lrp4 mRNA into the pcDNA6.2TM-GW vector 
(pcDNA6.2TM-GW-miR). To reduce possible off-target effects, the microRNAs were designed 
with the help of the miRNA designer software from Invitrogen. Additionally, a BLAST search 
with all sequences was performed to confirm the absence of similar sequences in other mRNA 
transcripts. To test the efficiency of RNA interference, HEK cells were co-transfected with the 
pCMV-LRP4 construct plus the pcDNA6.2TM-GW-miR plasmid or the pcDNATM6.2-
GW/EmGFP as a control. Cells were collected 72 hours after transfection and total protein was 
extracted. Western blotting identified mir1232 and mir1544 as most effective in reducing LRP4 
protein levels (Figure 3.22). 
	
Figure 3.22. Generation and test of microRNAs targeting LRP4 
(A) Test of knock down efficiency of the microRNAs. HEK293 cells were co-transfected with pCMV-
LRP4 and either the microRNA plasmids or the empty vector as a negative control. Note that miR1232 
and miR1544 led to a significant knock down of LRP4, whereas miR6854 and miR7072 were not as 
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effective in reducing LRP4 levels. (B) Quantification of the LRP4 expression levels using an ImageJ plugin. 
Note that miR1232 and miR1544 can knock down LRP4 with an efficiency of almost 95% and 90%, 
respectively.  
 
To enhance knock down of LRP4, these two microRNAs were then chained together with the 
RFP cDNA sequence in a CAG-driven-promoter expression vector (CAG-miRLRP4-RFP) and 
subsequently used for transfections in cortical and hippocampal neurons. As a control for the 
transfections, we used the pCAG-RFP vector lacking the microRNA sequences (Figure 3.23). 
Immunostaining of cortical neurons confirmed the effectiveness of the microRNAs in reducing 
LRP4 protein levels. At the same time these experiments also further confirmed the specificity of 
the antibody (Figure 3.23). 
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Figure 3.23. Constructs for expression of RFP, LRP4 and miRLRP4 
(A) Constructs encoding RFP, LRP4 and miRLRP4 (the miR1232 and miR1544 chained together). 
Transgene expression is driven by the CAG promoter, besides the LRP4 expression that is driven by the 
synapsin (SYN) promoter. (B) E14 cortical cultures transfected with RFP encoding construct (upper set of 
pictures). Immunostaining for RFP (red channel) and LRP4 (green channel) shows the endogenous levels 
of LRP4 in the transfected neuron (white arrow). Double transfected cortical neurons with RFP and LRP4 
encoding constructs (middle set of pictures). Immunostaining for RFP (red channel) and LRP4 (green 
channel) shows that the neuron is transfected with both plasmids (white arrow). Cortical neurons 
transfected with miRLRP4 encoding construct (lower set of pictures). Immunostaining for RFP (red 
channel) and LRP4 (green channel) reveals that the neurons that are transfected with the miRLRP4 do not 
show immunoreactivity for LRP4. Scale bars: 50 µm. 
	
3.4.6 Knockdown of LRP4 affects dendritic development and synapse formation 
in vitro 
In order to test the effects of down regulation of LRP4 in vitro, I co-transfected primary cortical 
and hippocampal neurons at DIV3 with pSYN-GFP:actin in combination with either the 
pCAG-miRLRP4-RFP or with the pCAG-RFP vector as control. The effect was analyzed 7-9 
days post transfection. I quantified the number and length of dendrites and the density of spines 
and synapses. Neurons transfected with pSYN-GFP:actin and pCAG-RFP had a morphology 
that was indistinguishable from untransfected neurons (data not shown), demonstrating that the 
transfection and the expression of a transgene itself did not influence neuronal morphology. In 
contrast, knockdown of LRP4 in cortical and hippocampal neurons led to a significant decrease 
in the number of primary dendrites extending from the neuron soma (2.22 ± 0.14 in cortical, 3.8 
± 0.3 in hippocampal, p<0.01 and p<0.05, respectively) and to a decrease in the density of spine-
like protrusions (3.33 ± 1.13/ 20 µm in cortical and 5.97 ± 0.65/ 20 µm in hippocampal 
neurons, p<0.01; Figure 3.19). In addition, the density of puncta labeled by antibodies against 
presynaptic proteins was decreased (bassoon: 0.31 ± 0.06/µm in hippocampal, p<0.05; SV2: 0.3 
± 0.009/µm in cortical, p<0.05), whereas the density of PSD95 puncta was not significantly 
affected (0.52 ± 0.03/µm, p=0.1807; Figure 3.21). The length of the primary dendrites was also 
significantly increased in cortical neurons (134.7 ± 8.88 µm, p<0.05), but was not significantly 
affected in hippocampal neurons (179.8 ± 35.85 µm, p=0.1158; Figure 3.19). 
These results demonstrate that LRP4 knockdown has the opposite effect on dendritic process 
number, dendritic length and density of synaptic puncta compared to the overexpression of 
LRP4. Overall, these results confirm a role of LRP4 in regulating dendritic development and 
synapse formation in cortical and hippocampal neurons in vitro. The results also reveal that 
hippocampal and cortical neurons react differently to LRP4 knockdown.	
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3.4.7 Knockdown of LRP4 reduces the number of direct presynaptic partners in 
dissociated neuronal cultures 
Our results indicated that LRP4 knockdown significantly reduces the number of synapses and 
spine-like protrusions in hippocampal and cortical neurons. Therefore, I next investigated to 
which extent LRP4-loss-of-function affected the integration of neurons into a neuronal network. 
To this end, I used a rabies virus-mediated monosynaptic tracing technique (Wickersham et al., 
2007b) which allows the visualization of all neurons presynaptic to a transfected neuron. Briefly, 
cortical neurons in culture were transfected with a retroviral vector encoding the EnvA-receptor 
TVA, the rabies virus glycoprotein G, which is responsible for retrograde transport of the virus 
across synapses and with the fluorescence reporter construct DsRedExpress2 (Figure 3.24). This 
makes neurons susceptible to subsequent primary infection by the G-deficient, eGFP-encoding 
EnvA-pseudotyped rabies virus (RABV) and capable of retrograde transfer of the virus to the 
immediate presynaptic partner cells (Wickersham et al., 2007a). The schemes B and C in Figure 
3.24 depict the general strategy for monosynaptic tracing of presynaptic partners of neurons in 
vitro. Delivery of G and TVA-encoding plasmid together with either pCAG-RFP or pCAG-
miRLRP4-RFP followed by RABV infection resulted in the appearance of double reporter-
positive neurons (starter cells), indicating that they had received both the plasmids and the virus 
(Figure 3.24 D, white arrows). I also observed cells expressing only eGFP but not RFP, 
indicating transsynaptic transmission of RABV from the starter neurons to their presynaptic 
partners (Figure 3.24 D). Further analysis showed that the number of direct presynaptic partners 
of LRP4 knockdown neurons was significantly lower when compared to control neurons (Figure 
3.24 E). These results demonstrate that LRP4 is necessary for the establishment of neuron-to-
neuron synaptic contacts and, therefore, has an important role in the integration of neurons into 
neuronal circuits in cultured CNS neurons. 
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Figure 3.24. Knockdown of LRP4 in dissociated neuronal cultures decreases the number 
of presynaptic partners 
(A) Schematic representation of the RABV and Glyco-TVA constructs used to investigate the number of 
functional presynaptic connections after LRP4 knockdown. (B) Experimental design for tracing 
monosynaptic connections in cortical neuronal cultures via consecutive delivery of G- and TVA-expression 
construct and RABV. (C) Timeline of the experimental protocol. (D) Representative examples of cortical 
neurons from E14 embryos after 12 DIV co-transfected with the G/TVA encoding vector and either 
pCAG-RFP (left panel) or pCAG-miRLRP4-RFP (right panel), followed by RABV infection. Arrows: 
double-transduced starter neurons. Note that the number of GFP+ cells surrounding a GFP+/RFP+ 
(starter) neuron is lower after knockdown of LRP4. (E) Ratio of RABV-traced cells versus GFP/RFP 
double positive starter neurons in control and knockdown conditions. The number of direct presynaptic 
partners is reduced to approximately 50% in neurons after knockdown of LRP4. Data show mean +/- SD 
from three independent experiments. (**p<0.01, unpaired t-test with Welch’s correction). Scale bar: 100 
µm.   
3.5  TM-agrin is required for the LRP4-mediated effect on dendritic 
development 
At the neuromuscular junction, LRP4 is the agrin receptor (Zhang et al., 2008b; Kim et al., 
2008). To test if an interaction of agrin with LRP4 is also required for the effects on dendrite 
morphology, I first confirmed that the two proteins colocalized in the CA1 region of the adult 
mouse hippocampus using specific antibodies (Figure 3.25). Since agrin has been shown to be 
concentrated at CNS synapses (Mann and Kröger, 1996; Koulen et al., 1999; Ksiazek et al., 
2007), the colocalization of agrin and LRP4 further supports the idea that LRP4 accumulates at 
CNS synapses. Since previous studies have shown that the transmembrane form of agrin (TM-
agrin) is expressed in hippocampal neurons (Burgess et al., 2000; Neumann et al., 2001), our 
results also demonstrate a colocalization of LRP4 with this particular agrin isoform at CNS 
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synapses. To further analyze the colocalization, cells isolated from the E14 cerebral cortex were 
cotransfected with the pCAG-RFP and the pSYN-LRP4 vectors on DIV2 and subsequently with 
pSYN-GFP:actin and pSYN-TMagrin on DIV3. Analysis of the sites of neuronal contacts by 
confocal microscopy revealed that TM-agrin was highly concentrated at contact sites between 
dendrites overexpressing LRP4 and axons overexpressing TM-agrin (Figure 3.25, panel B). In 
contrast, neurons overexpressing TM-agrin did not concentrate at the site of contact to neurons 
in which LRP4 had been knocked down by transfection with the LRP4 miRNAs (Figure 3.25, 
panel C). These results show an influence of LRP4 on TM-agrin localization in neurons. They 
also suggest that LRP4 directly interacts with TM-agrin in neurons and might be involved in 
aggregating TM-agrin at the contact sites.  
To determine if agrin is involved in the LRP4-mediated effects on dendritic growth, I analyzed 
the response of dendrites of cortical neurons to LRP4 overexpression in the presence or absence 
of anti-agrin antibodies (Figure 3.25). These antibodies were generated against the 95 kDa C-
terminal fragment of mouse agrin, which has been shown to be responsible for LRP4 binding 
and acetylcholine receptor (AChR) aggregation at the NMJ (Eusebio et al., 2003). Preimmune 
serum did not have any effect on the number and length of primary dendrites (data not shown). 
In contrast, treatment of neurons overexpressing LRP4 with anti-agrin antibodies reduced the 
number of primary dendrites (5.46 ± 0.65 compared to 10.27 ± 0.32 in untreated cultures, 
p<0.001) and increased their length (105.9 ± 12.47 µm compared to 33.97 ± 1.21 µm in 
untreated cultures, p<0.0001) but had no detectable effect on untransfected neurons (data not 
shown). Thus, addition of anti-agrin antibodies reversed the effect of LRP4 overexpression 
suggesting that agrin is involved in the effects mediated by LRP4 on the dendritic morphology of 
CNS neurons in vitro. 
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Figure 3.25 Colocalization and functional interaction of LRP4 and the transmembrane 
form of agrin on dendrites in vitro 
(A) Agrin (red channel) and LRP4 (green channel) staining of the CA1 region of the hippocampus. Note 
that many but not all agrin-positive puncta colocalized with LRP4 puncta. (B) Representative example of 
E14 cortical neurons sequentially co-transfected with pCAG-RFP and pSYN-LRP4 on DIV3 (in red) and 
pSYN-GFP:actin and pSYN-TMagrin on DIV4 (in green). Note that TM-agrin is concentrated at contact 
sites between dendrites overexpressing LRP4 and axons overexpressing TM-agrin (insets a and b; a’ and b’ 
represent orthogonal projections), indicating that LRP4 and TM-agrin from two different cells might 
interact. (C) Representative example of E14 cortical neurons sequentially co-transfected with pCAG-
miRLRP4-RFP on DIV3 (in red) and pSYN-GFP:actin and pSYN-TMagrin on DIV4 (in green). Note 
that TM-agrin is not concentrated at contact sites between dendrites of neurons in which LRP4 expression 
has been knocked down and axons overexpressing TM-Agrin (insets c and d; c’ and d’ represent 
orthogonal projections). (D) Representative examples of dissociated cells from the E14 cortex co-
transfected with pSYN-GFP:actin and pSYN-LRP4. Neurons were treated with the soluble C-terminal 
125 kDa (A4B8) chicken agrin fragment or cultured in the presence of anti-agrin antibodies. Note that in 
the presence of anti-agrin antibodies as well as in the presence of the soluble agrin fragment ameliorates the 
dendritic phenotype caused by LRP4 overexpression. (E-F) Quantification of the number (E) and length 
(F) of primary dendrites extending from cortical neurons overexpressing LRP4 after treatment with the 
soluble C-terminal agrin fragment (red bars) or with anti-agrin antibodies (black bars). Note that 
treatment with either the antibodies or with soluble agrin significantly decreased the number (E) and 
increased the length (F) of primary dendrites compared to transfected neurons in the absence of antibodies 
or agrin. Data show mean +/- SD from three independent experiments, n = 10 neurons per 
condition/experiment. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 One-way ANOVA with Dunnett’s 
posthoc test. Scale bars: 50 µm (A and D), 25 µm (B and C), 10 µm (insets in B and C) and 2 µm (insets 
in A). 
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3.6  LRP4-mediated effects on dendritic development are ameliorated by 
soluble agrin and are independent of MuSK 
The effect of anti-agrin antibodies on dendrite growth suggested that an interaction of LRP4 
with TM-agrin is necessary for the formation of a normal dendritic arbor. To confirm this, I 
investigated whether a soluble C-terminal fragment of agrin, which is able to bind to LRP4 but is 
not anchored to the cell membrane, interferes with the interaction of LRP4 with TM-agrin for 
example by competing with the agrin binding site on the LRP4 protein. To this end, I analyzed 
the effects of LRP4 overexpression (using the pSYN-GFP:actin and pSYN-LRP4) in the presence 
or absence of the C-125 fragment (A4B8 isoform) of chick agrin (Tsim et al., 1992; Pevzner et 
al., 2012). Chick agrin is known to function in mouse tissue in vitro and in vivo (Moll et al., 
2001). Cultures were fixed 3-4 days after transfection and agrin addition and morphometric 
analysis was performed as described above. The presence of the soluble agrin fragment led to a 
decrease in the number (6.37 ± 1.03 compared to 10.27 ± 0.32 in untreated cultures, p<0.01) 
and an increase in the length (68.48 ± 6.2 µm compared to 33.97 ± 1.21 µm in untreated 
cultures, p<0.01) of primary dendrites of neurons overexpressing LRP4 compared to neurons 
transfected with the empty vector (Figure 3.25). Thus, the presence of soluble agrin ameliorated 
the effect of LRP4 overexpression and mimicked the effect of the anti-agrin antibodies, resulting 
in a dendritic morphology that resembled that of control neurons. Thus, the soluble isoform of 
agrin rescued the LRP4-mediated effects on dendritic arborization in cortical neurons similar to 
anti-agrin antibodies. This strongly suggests that an interaction of LRP4 with TM-agrin is 
required for normal dendritic arborization of cortical neurons. Furthermore, the equivalent 
effects of the anti-agrin antibodies and the soluble agrin fragment suggests that the membrane 
association of agrin is required for the LRP4-mediated changes in dendritic morphology of 
cortical neurons. 
At the NMJ, the effect of agrin and LRP4 on synapse formation is mediated by the tyrosine 
kinase MuSK (Glass et al., 1996). Since MuSK is also expressed by CNS neurons and 
concentrated at synapses (Ksiazek et al., 2007) we investigated whether it is also involved in the 
agrin/LRP4-mediated effect on dendritic arbor formation by analyzing the effect of LRP4 
overexpression in hippocampal neurons from MuSK knockout mice (DeChiara et al., 1996). 
Hippocampal neurons from MuSK+/+, MuSK+/- and MuSK-/- mice were co-transfected with 
the pSYN-LRP4 plasmid and pSYN-GFP:actin or with only the pSYN-GFP:actin vector as 
control (Figure 3.26). Overexpression of LRP4 in wildtype, MuSK+/- and MuSK-/- neurons 
resulted in an increased number and decreased length of primary dendrites as detailed above in 
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neurons from all three genotypes (Figure 3.26). Thus, the absence of MuSK did not affect the 
LRP4-induced changes in dendritic morphology.  
	
Figure 3.26. Overexpression of LRP4 in MuSK+/+, MuSK+/- and MuSK-/- 
hippocampal neurons 
Representative examples of dissociated cells from the E18 hippocampus of MuSK+/+, MuSK+/- and 
MuSK-/- mice co-transfected with SYN-GFP:actin and SYN-LRP4 plasmids (lower panel/set of pictures) 
or with SYN-GFP:actin plasmid alone as a vector control (upper panel/set of pictures). Note that the 
dendritic phenotype caused by LRP4 overexpression is observed in all the three genotypes, thus indicating 
that is independent of MuSK expression (Scale bar 50 µm).   
	
Taken together, these results demonstrate that LRP4 regulates dendrite growth in CNS neurons 
through interaction with TM-agrin, in a MuSK-independent manner, suggesting that different 
pathways are initiated by LRP4 in CNS neurons and at the NMJ. 
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4 Discussion 
LRP4 is a single-pass transmembrane protein with important functions in bone homeostasis, 
limb patterning, kidney formation, and placode development (Ahn et al., 2013; Choi et al., 
2013; Johnson et al., 2005; Karner et al., 2010). In the nervous system, the function of LRP4 has 
been best characterized at the neuromuscular junction where it serves as a receptor for the 
extracellular matrix protein agrin. Upon agrin binding, LRP4 activates the tyrosine kinase MuSK 
which subsequently induces a signaling cascade resulting in the formation of most, if not all, 
postsynaptic specializations (Wu et al., 2010). LRP4 expressed by skeletal muscle fibers also acts 
retrogradely to induce the differentiation of the presynaptic terminal (Wu et al., 2012; Yumoto 
et al., 2012). Consequently, reduced function of LRP4 causes serious neuromuscular deficits, as 
indicated for example by the effects of anti-LRP4 autoantibodies in myasthenia gravis (Pevzner et 
al., 2012; Higuchi et al., 2011; Zhang et al., 2012), and by LRP4 knockout mice, which die at 
birth due to lack of neuromuscular junctions and therefore respiratory musculature failure 
(Weatherbee et al., 2006). These and other results have established a fundamental role of LRP4 
during NMJ formation, maintenance and function. This thesis examines the physiological role of 
LRP4 in the CNS. Specifically, I focused on analyzing the distribution of LRP4 in different areas 
of the CNS and the function of LRP4 during synapse formation, spine development, dendrite 
outgrowth and branching in primary cortical and hippocampal neurons. My results reveal a 
widespread distribution of LRP4 in many, but not all, CNS neurons and a prominent function 
in dendritic arborization and synaptogenesis. 
In this study, the expression pattern of LRP4 in the CNS was determined. For this purpose, two 
polyclonal antibodies targeting different regions of the protein (one against an intracellular and 
one against a juxtamembrane extracellular epitope) were generated in rabbits. These antibodies 
were used together with the two commercially available antibodies throughout my study. In 
principle, all the four sera gave similar results in the initial control experiments performed to test 
their selectivity and specificity. First, all four antibodies were able to specifically and efficiently 
recognize LRP4 upon overexpression in HEK293 cells by immunocytochemistry. Confirming 
the immunocytochemistry results, LRP4 protein was detectable as a 250 kDa band in Western 
blotting using lysates from HEK293 cells upon overexpression of LRP4. All four antibodies were 
also able to detect endogenous LRP4 at neuromuscular junctions from adult mouse skeletal 
muscle by immunohistochemistry. The specificity of the antibodies was tested using competition 
experiments in vivo in which the antibodies were preincubated with an excess of the respective 
peptide against which the antibody was generated and subsequently used for immunostaining of 
the NMJs. Furthermore, specificity was demonstrated by the absence of LRP4 staining upon 
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usage of microRNAs specifically designed to knock down LRP4 (see paragraph 2.1). These data 
collectively established the specificity and selectivity of the antisera for LRP4 in 
immunohistochemistry and Western blotting.	
4.1  Expression of LRP4 in the murine brain 
The antisera were subsequently used to investigate – for the first time – the localization and 
distribution of the LRP4 protein in the adult murine brain. Previous studies reported a 
widespread lrp4 mRNA expression in the rat CNS and a concentration of LRP4 protein in the 
synaptosomal protein preparation (Tian et al., 2006; Gomez et al., 2014). Accordingly, 
endogenous LRP4 was detectable as a 250 kDa band in membrane fractions isolated from adult 
mouse cortex, hippocampus, cerebellum and olfactory bulb (see Figure 3.7). Moreover, and 
consistent with previous in situ hybridization data in the adult rat brain (Tian et al., 2006), I 
demonstrated that LRP4 is highly expressed in neuronal populations distributed in the cortex, 
hippocampus, cerebellum and olfactory bulb from the adult mouse brain. Both the commercial 
and the generated-in-house antibodies against the intracellular region of LRP4 revealed an 
equivalent distribution in the mouse brain. Interestingly, the distribution of LRP4 in the mouse 
brain did not appear to be homogeneous, but apparently was enriched in specific neuronal 
subpopulations. These included neurons from all cortical layers, pyramidal neurons of the CA1 
and CA3 hippocampal regions, cerebellar Purkinje neurons and mitral cells of the olfactory bulb. 
Moreover, the colocalization of LRP4 and agrin at CNS synapses demonstrates a concentration 
of LRP4 at interneuronal synapses and makes a functional cooperation of the two proteins in the 
CNS possible, similar to what has previously been described at the NMJ (Kim et al., 2008; 
Zhang et al., 2008). 
Interestingly, LRP4 protein was not detected in adult-born neuroblasts of the subgranule zone 
(SGZ) of the dentate gyrus. Similarly, LRP4 is absent in the other well-known neurogenic niche 
of the adult murine brain, the subependymal zone (SEZ). These data indicate that the expression 
of LRP4 is restricted to the neurons generated during embryonic or early postnatal development. 
Consistently, Burk et al. (Burk et al., 2012) observed no lrp4 mRNA expression in neuroblasts 
migrating along the rostral migratory stream to the olfactory bulb. Unlike neurons that are born 
in the embryo, adult-born generated neurons of the SGZ and SEZ have to synaptically integrate 
into preexisting mature and functional networks and little is known about the molecular signals 
and mechanisms underlying this integration. The absence of LRP4 expression in adult neural 
stem cells of both the neurogenic niches might suggest that LRP4 is not required for their 
survival and synaptic integration into the preexisting neuronal networks of the hippocampus and 
olfactory bulb. However, one interesting observation is the distribution of LRP4 in the mitral 
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cell layer of the olfactory bulb, a cell population that represents the main synaptic target for 
newly arriving interneurons (Ming and Song, 2011). Likewise, LRP4 is highly expressed in the 
CA3-pyramidal neurons of the hippocampus, another cell population where adult-born granule 
cells of the dentate gyrus send their mossy fibers and therefore their synaptic outputs (Toni et al., 
2008). Related to these results is that agrin is strongly expressed in neuronal precursors in the 
RMS, OB and hippocampus (O’Connor et al., 1994; Cohen et al., 1997). Taken together, the 
distribution of LRP4 in the MCL of the OB and the CA3 hippocampal region and the 
distribution of agrin in the respective synaptic partners could suggest an interaction of the two 
proteins that may be sufficient for synaptogenesis in the CNS, similar to what was previously 
observed at the NMJ (Kim et al., 2008; Zhang et al., 2008).    
In contrast to its expression in neurons, we were not able to detect LRP4 protein in glial cells 
using immunohistochemistry in the adult murine cortex or in primary neuronal cultures. This 
demonstrates that the effects I observed are due to neuronal LRP4. However, our results do not 
completely rule out an influence of glial cells.	
4.2  The role of LRP4 in dendrite formation 
In this study, the effect of LRP4 on the dendritic arborization of cortical and hippocampal 
neurons in vitro was investigated. To this end, I used constructs specifically designed to 
overexpress and knockdown LRP4 in hippocampal and cortical neurons. Both neuronal types 
responded to LRP4 overexpression by changes in dendritic arborization with an increased 
number of primary dendrites extending from the neuronal cell body, that were significantly 
shorter when compared to control neurons. A knockdown of LRP4 in the neurons had the 
opposite effect, i.e. fewer, but significantly longer, dendritic processes were generated and the 
density of synapse-like specializations was decreased. LRP4-deficient mice rescued from perinatal 
death by re-expression of LRP4 in the neuromuscular system as well as mice with a selective loss 
of the intracellular and the transmembrane domains showed a significantly decreased density of 
dendritic spines in the CA3-hippocampal region, consistent with my results, but had no gross 
anatomical abnormalities in the prenatal and adult hippocampus, cortex and cerebellum (Gomez 
et al., 2014; Pohlkamp et al., 2015). Thus, lack of LRP4 does not lead to a general reduction in 
the number of CNS neurons. Consistently, we did not observe an increase of apoptotic or dying 
cells in our cultures after overexpression or knockdown of LRP4.  
With regard to the dendritic phenotype, it is currently unclear why similar changes in dendritic 
morphology were not observed in LRP4-deficient brains in vivo. One possible explanation for 
the discrepancy between our in vitro data and the in vivo data is the activation of redundant or 
compensatory mechanisms in vivo, which ameliorate the dendritic phenotype observed in vitro. 
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Compensatory activity within the family of LRP proteins has been suggested during limb 
development (Li et al., 2010). Potential candidates with compensatory activity could be LRP1 
which, like LRP4, is concentrated in the PSD fraction (May et al., 2004) or LRP10, which is 
structurally almost identical to LRP4 (Brodeur et al., 2012; Lane-Donovan et al., 2014).  
Time-lapse video microscopy of neurons overexpressing LRP4 and control neurons revealed that 
within a few hours after LRP4 overexpression, dendritic extension stopped and the dendrites 
appeared rather stable, without extending or retracting. Thus, overexpression of LRP4 in neurons 
caused a severe reduction in dendrite process extension. The reduction of growth speed after 
LRP4 overexpression appears to be similar to what has been reported as a function of LRP4 at 
the NMJ, i.e. the transformation of a highly motile growth cone into a stable presynaptic 
terminal (Wu et al., 2012; Yumoto et al., 2012). Accordingly, in LRP-/- mice the α-motoneuron 
growth cone continues to grow along the muscle fiber and never develops into a presynaptic 
terminal (Weatherbee et al., 2006). Thus, LRP4 overexpression might have similar functional 
consequences in dendritic growth of hippocampal and cortical neurons as it has in axons of α-
motoneurons.	
4.3  The role of LRP4 in spine and synapse formation 
In this study, the effect of LRP4 on spinogenesis and synapse formation was also investigated. I 
observed that a decreased LRP4 expression in cultured cortical and hippocampal neurons lead to 
a reduced density of spine-like protrusions and dendrite-associated synapse-like specializations, 
including bassoon-, synaptobrevin2- and PSD95 puncta. In contrast, overexpression of LRP4 
had the opposite effect, i.e. increased densities of spine-like protrusions and synapse-like 
specializations. The knockdown effects of LRP4 in spine density and synapse number are in 
agreement with the reduced number of spines on dendrites in vivo (Gomez et al., 2014; 
Pohlkamp et al., 2015). However, it is unknown if the reduced spine density observed in vivo 
was due to a direct effect of LRP4 on neurons or indirectly caused by affecting glial cells. Our 
knockdown and overexpression experiments were designed to exclusively affect neurons, but not 
glial cells. In addition to this, we were not able to detect LRP4 in glial cells neither in vivo nor in 
vitro based on our immunochemical studies. Taken together, it appears likely that the effect 
observed in vitro in our culture system and also in vivo by other laboratories (Gomez et al., 2014; 
Pohlkamp et al., 2015) is, at least in large parts, caused by neuron-derived LRP4. Although we 
cannot exclude a role of glial cell-derived LRP4 during CNS development, our results strongly 
suggest that the cognitive deficits, altered LTP and reduced spine density previously observed in 
the hippocampus of adult mice with LRP4-deficient brains (Gomez et al., 2014) involve neuron-
derived LRP4 rather than glia cell-derived. 
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Little is known about the cellular and molecular mechanisms underlying dendrite extension and 
branching in the CNS. Dendritogenesis is a highly dynamic process that is influenced by 
synaptic activity as well as by signals from the immediate environment (Cheng and Poo, 2012; 
Dong et al., 2014). The opposite effects of LRP4 overexpression and knockdown on dendrite 
number, length and on synapses opens the possibility that all three effects might depend on each 
other. One possibility is that the reduced density of synapses induced by LRP4 knockdown 
causes a reduction in the number of primary dendrites and an increase in dendritic length, 
whereas the overexpression of LRP4 causes an increase in synaptic density which results in a 
subsequent decrease in dendritic mobility and an increased number of shorter dendrites. Thus, 
the effect on dendritic arborization may be secondary to differences in synapse number. 
Alternatively, synapse formation and dendritic arbor formation could be independently caused 
by changes in LRP4 expression. This hypothesis is consistent with the changes observed in 
LRP4-deficient brains, which exhibit a reduction in synaptic density without a significant change 
in the dendritic arborization (Gomez et al., 2014; Pohlkamp et al., 2015). Interestingly, neurons 
in the brain of agrin-/- mice, in which the perinatal lethality has been rescued by motoneuron-
specific expression of agrin, also develop fewer synapses and shorter dendrites (Ksiazek et al., 
2007), suggesting that the LRP4-mediated effect on dendritic morphology might be caused by 
an interaction of LRP4 with agrin.  
4.4  Agrin and LRP4 might act together to regulate dendritic development 
At the NMJ, the interaction of LRP4 with agrin is crucial for synaptogenesis (Wu et al., 2010). 
In our culture system, I observed that the inhibition of the LRP4-agrin interaction by anti-agrin 
antibodies or the addition of a soluble C-terminal agrin fragment reversed the effects of LRP4 
overexpression. The most likely interpretation of these results is that both treatments interfered 
with the agrin-LRP4 interaction by either blocking the agrin binding to LRP4 (antibodies) or by 
competing with the ligand-binding site of LRP4 (soluble agrin fragment). The comparable effects 
of both treatments on the LRP4-overexpression-mediated effects in CNS neurons suggest TM-
agrin as one potential binding partner for LRP4 in the CNS. Thus, LRP4-TM-agrin interactions 
might shape the dendritic morphology and influence the formation of synapses in cultured 
neurons of the CNS. My results also suggest an important role of the membrane anchor of TM-
agrin in the LRP4 overexpression-mediated effects, since the soluble LRP4-binding part of agrin 
interfered with the changes in dendritic morphology. In contrast, the same soluble agrin 
fragment can bind to LRP4 and induce AChR aggregation in vitro in primary muscle cultures 
(Pevzner et al., 2012). Thus, the transmembrane anchor might locally stabilize the agrin-LRP4 
interaction, securing a continuous presence of TM-agrin at synapses. A soluble agrin fragment 
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has previously been shown to induce both dendritic elongation and dendritic branching in 
hippocampal cultures, whereas the cultured hippocampal neurons depleted of agrin extended 
shorter dendrites compared to controls (Mantych and Ferreira, 2001). Our results might 
therefore suggest that the effect of soluble agrin is mediated by LRP4. 
At the NMJ agrin binding to LRP4 activates the tyrosine kinase MuSK. Since MuSK is also 
present in the CNS (Ksiazek et al., 2007) and mice after MuSK knockdown exhibit deficits in 
memory consolidation and LTP (Garcia-Osta et al., 2006) similar to those observed in mice 
expressing a truncated LRP4 protein which lacks the intracellular- and the transmembrane 
domain (LRP4ECD/ECD; Choi et al., 2013; Pohlkamp et al., 2015) the hypothesis was raised that 
MuSK and LRP4 functionally interact to maintain normal synapse function also in the CNS. 
Interestingly, the effects of LRP4 overexpression on dendritic branching did not depend on 
MuSK. This does not exclude an interaction of LRP4 with MuSK in adult neurons or glial cells, 
but suggests that the molecular mechanism of synapse formation in the CNS might differ from 
that at the NMJ. 
4.5  Functional consequences of LRP4 knockdown in CNS neurons  
Using a rabies virus-mediated monosynaptic tracing technique (Wickersham et al., 2007), I 
demonstrated that the number of functional presynaptic partners after LRP4 knockdown was 
significantly reduced. This technique depends on the presence of functional synapses and, thus, 
our results suggest that the reduction of synapse-like specializations after miRNA-mediated LRP4 
knockdown is paralleled by a reduced number of functional synaptic inputs to the transduced 
neuron. Since the rabies virus can only be transported in a retrograde manner, from the 
postsynaptic to the presynaptic neuron, our results also suggest that LRP4 has a retrograde effect 
from the postsynaptic dendrites to the presynaptic terminals. Whether a similar activity of LRP4 
also occurs at the axon terminal cannot be analyzed by this technique and, thus, remains to be 
determined. Interestingly, synapses were reduced by 30% in agrin-deficient brains (Ksiazek et al., 
2007), suggesting overlapping and possibly interdependent functions of LRP4 and agrin in 
synapse formation at the NMJ and in the CNS.  
4.6  Conclusions and future prospects 
The present study focuses mostly on the cerebral cortex and hippocampus. However, LRP4 has a 
widespread expression pattern in the CNS, including neuronal populations outside the forebrain, 
such as the Purkinje cells of the cerebellum or ganglion cells in the retina. It is therefore 
conceivable that LRP4 generally regulates dendritogenesis and synapse formation in other regions 
of the brain beyond the cerebral cortex and the hippocampus. This study provides the first 
indication for a function of LRP4 in dendritic branching and synapse formation in the 
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developing CNS, opening up avenues for elucidating the underlying molecular mechanism in 
other regions of the CNS. Considering that defects in dendrite formation and synapse 
development or maintenance are crucial in neurodevelopmental disorders such as schizophrenia, 
Down’s syndrome and autism spectrum disorders (Caroni et al., 2012), it will be interesting to 
further elucidate the molecular contribution of LRP4 in pathologically altered brains. 
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6 Appendix 
6.1  Appendix 1: List of abbreviations 
AChR: acetylcholine receptor 
CAG: chicken-β-actin 
cDNA: complementary deoxyribonucleic acid 
CMV: cytomegalovirus 
CNS: central nervous system 
DAPI (4΄,6-diamidino-2-phenylindole) 
Dcx: doublecortin 
DIV: day in vitro 
E: embryonic day 
eGFP: enhanced green fluorescent protein 
G: rabies virus glycoprotein 
GABA: g-amino-butyric acid 
GFAP: glial fibrillary acidic protein 
HEK: human embryonic kidney 
kD: kilo Daltons 
LRP4: low-density lipoprotein receptor-related protein 4 
MAP2: microtubule associated protein 2 
mRNA: messenger ribonucleic acid 
MuSK: muscle specific tyrosine kinase 
NMJ: neuromuscular junction 
PFA: paraformaldehyde 
RABV: EnvA-pseudotyped rabies virus 
RFP: red fluorescent protein 
SEZ: subependymal zone 
SYN: synapsin 
SV2: synaptobrevin2 
TM: transmembrane 
TVA: tumor virus A 
WB: Western blotting 
µm: micrometer	
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6.2  Appendix 2: List of figures 
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Figure 3.20 Overexpression of LRP4 in cultured cortical neurons reduces the dynamics of 
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Figure 3.21 LRP4 affects the number of pre- and post-synaptic specializations in neuronal 
cultures 
Figure 3.22 Generation and test of microRNAs targeting LRP4 
Figure 3.23 Constructs for expression of RFP, LRP4 and miRLRP4 
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6.3  Appendix 3: List of tables 
	
Table 1  Primary antibodies  
Table 2  Secondary antibodies 
Table 3  Buffers and solutions  
Table 4  Media for cells and bacteria culture 
Table 5  Prokaryotic and eukaryotic cell lines  
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6.4  Appendix 3: Plasmid maps 
6.4.1 pCMV-LRP4-IRES-eGFP 
 
6.4.2 pSYN-LRP4 
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6.4.3 pcDNA6.2-GW/EmGFP 
	
6.4.4 pcDNA6.2-GW/mir1232 
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6.4.5 pcDNA6.2-GW/mir1544 
	
6.4.6 pcDNA6.2-GW/mir6854 
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6.4.7 pcDNA6.2-GW/mir7072 
	
6.4.8 pcDNA6.2-GW/mir1232_1544 
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6.4.9 pENTR1A_mir1232_1544 
	
6.4.10 pCAG-miR-RFP 
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